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Abstract
In a search for fibroblast growth factor (FGF}-regula!ed early response genes. four
eDNA fragments were isolated via a polymerase chain reaction-based differential disJH3Y
procedure. The eDNA fragments represent portions of genes that were either activated or
repressed in Stage 8 Xenopw lafilis explants after a 30 minute treaanent with 1000g/mJ
XFGF-2. One 498bp eDNA fragment. named Band V, represents a gene that is
downregulated by FGF treatment. This gene is expressed at Stages 8. 9 and 15 in the
developing Xenopus embryo. A Genbank homology search program revealed similarity
of Band V to distinct regions in an alternatively spliced myocyte enhancer faclor, the v-j·
c region of aT-ceil receptor gamma chain. a Meprin A beta-subunit precursor and a
myosin I heavy chain-like protein. The three other eDNA bands isolated from the
differential display were chosen due to apparent uprc:gulalion by FGF. The 449bp Band
VIAIB eDNA fragment possesses regions of similarity to the reactive centre of murine
serine proteinase inhibitor 2.4 and a contrapsin·related MC·7 precursor. Upregulation of
Band VIA/B was not confinned because gene expression could not be detected via PCR
in X~nopus explanu or lhroughoul development. The lhird Band 11/12, is a 636bp cDNA
fr3.~nt whose gene is only expressed at Stage 8 of me: developing embryo and was
upregulated by FGF-2, in a PCR reaction. A database homology search showed that
Band 11112 was similar to a hypolhetical pro«:in. A~. 190bp DNA fragment
isolated from Band 12 was a portion of d1e c·mos proc:o-oncogene. The fourth and final
cDNA Band 22 is 517bp in size and represenu a previously cloned X~nopus l46kDa
nuclear splicing factor (Schmidt-Zachmann ~l at., 1998). This factor is eltpressed
throughout X~nopus development, and control of Band 22 gene expression by FGF·2
could not be confirmed.
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Chapter 1
Introduction
1.1 Growth Factors in Development and Oncoeenesis
Growth factors are small polypeptide molecules. essential for nonnal growth and
development of living organisms. TItey direct proliferation and differentiation of cells
and are necessary for the survi...a1 of specific tissues. Because growth factors are so
important (0; growth and development. lade of control of these molecules may be:
detrimental to the organism. Many of the genes activated by growth factors ale
oncogenes (Reviewed by Aaronson, 1991). Therefore. by learning about the roles growth
factors play in normal development. we may Ieam aboul their potential role in the
pathology of diseases such as cancer.
There are a number of growth factor families that have been c:haJ1JCterized to date.
They include epidennal growth factor (EGF). plalelct-derived growth factor (PDGF),
insulin-like growth factor (IGF) and fibroblast growth factor (FGF). All growth factor
families are important, however this study is focwscd on the role of the FGF family in
development.
FGFs arc involved in growth and developmental events such as angiogenesis. cell
proliferation and differentiation and are expressed in a number of cancers such as breast
carcinoma and Kaposi's sarcoma (reviewed in Baird and Klagsbrun, 1991). The current
knowledge of FGFs will be reviewed in the neKt section.
1.2 Fibroblast Growth Factors
Fibroblast growth factors compose a family of polypeptide molecules that possess
amino acid similarity. ability to bind FGF receptors (FGFR) and a heparin- binding
domain. There are II known FGFs to date (Table 1.1). Six other FGF similarity genes
have been cloned. however their specific functions are still unknown. Various roles for
FGF in nonnal processes have been delineated, including angiogenesis, wound repair,
nervous cell differentiation, and embryonic development. They also playa role in cell
proliferation. motility. differentiation and survival. Several FGF family members arc also
proto-oncogenes, and playa role in proliferation of cancer cells (reviewed in Baird and
KJagsbrun. 1991).
The most well characterized members of the FGF family are. acidic FGF (aFGF,
FGF-l) and basic FGF (bFGF. FGF-2). FOF-I and FGF-2 JXlssess 55% amino acid
similarity and bind to the same FOF receptors, however, they are expressed primarily in
different tissues (Baird and Klagsbrun, 1991).
Table 1.1 Members of the FGFFamily
Numerical Name Common Name
FGF-I aFGF
FGF-2 bFGF
FGF-3 1NT-2
FGF-4 kFGF. HST·I
FGF-5
-
FGF-6 HST-2
FGF-7 KGF
FGF-8 AIGF
FGF-9 GAF
XeFGF
FGF-IO KGF-2
FGF-II FHF-3
FGF-12 FHF-I
FGF-13 FHF-2
FGF-14 FHF-4
FGF·15
--
FGF-I was discovered by Gospodarowicz and colleagues. (1975) on the basis of
its ability to cause. proliferation and delayed differentiation in myoblasts. II was later
shown to stimulate proliferation in endothelial cells. FGF·I isex~ primarily in Ihe
adult brain and retina (reviewed by Gospodarowicz et at. 1987).
FGF-2 was discovered in 1974, also by Gospodarowicz, due to its ability to cause
ptoliferation and transfonnation of BAl..B/c3T3 cells. It is also very well conserved
throughout evolution, and widely ex:pressed in many tissues. suggesting a vital
physiological role (Gospodarowicl. 1987). Interestingly, neither FGF-I nor FGF·2
possesses a conventional signal sequence for release from the cell, however they have
both been isolated within the extracellular space (Baird and Klagsbrun, 1991). Currently,
Iheir method of secretion remains unknown. Since FGF-2 is the FGF used in Ihis study,
more about its role in development will be. covered in following sections.
FGF-3 is also known as INT-2. 1bc: gme was first discovered by Peters tt at,
(1983) due to its transeriplional activalion in cells by the mouse mammary rumor virus
(MMTVl and is therefore a proc:O«ICOgetle. FV·j is normally expressed in a variety of
stages in the developing embryo and is thought to playa role in development of tail. brain
derived structures and other epithelia in mouse (Tannahill l!t aJ.• 1992). It is rarely
ex:pressed in adult tissues and it has not displayed mitogenic potential. but has shown
ability to transfonn cenain NU{3T3 ceU lines (Dickson l!t aJ.• 1991).
FGF-4 is also known as human stomach tumor (hst.l). Hst-I. a known oncogene.
was originally identified from a human gast!;C tumor tissue (Sakamoto l!t ai. 1986).
Interestingly. it is found only 35kbp downstream of the int·} gene on chromosome II and
they have shown to be co-amplified in several types of cancers. Fgf-4 is also known to be
selectively expressed during development, in genn celllUmors, cancers such as Kaposi's
sarcoma and gastric cancers and mouse embryos (Yoshida tt ai. 1988).
Upon conducting transfection assays, to search for human oncogenes. Zhann and
colleagues. (1988) discovered FGF-5. Fgf-5 is expressed in mouse embryos al two
stages. 5114 -8 days post implantation and 91/2 -14112 days post implantation (Hebert et
ai" 1990). Expressional studies comparingfgf-4 andfgf-5 indicate that even though they
are both expressed in myocytes and other tissues during development, they have a distinct
role in development (Drucker and Goldfarb, 1993). Fgf·5 is expressed in the central
nervous system only of adult mice (Haub et of, 1990).
FGF-6 was first isolated due to its similarity to FGF-4, thus it was initially called
1Ist-2 (Maries et aI., 1989). FGF-6, like FGF4 demonstrates transfonning ability. It was
shown to transform Nllt3T3 cells and fonn a well-vascularized lUmOt in nude mice,
suggesting a role for FGF-6 in angiogenesis. It was also expressed in some human
leuk.emia cell lines (lida et al., 1992).
Keratinocyte growth factor (KGF) is the common name for FGF-7. It was
initially identified as a mitogen in the mouse NntJ3T3 cell line (Rubin et 01., 1989).
FGF-7 is thought to playa role in nonnal epithelial cell growth via a paracrine effect
lAaronsonetal..I99t).
An FGF thought to be important in mesoderm induction was cloned in Xenopus
by Isaacs, Tannahill and Slack. 1992. It is highly similar to mammalian FGF4 and FGF-
6. however is not thought to be the Xenopus homologue of either one. It was named
Xenopus embryonic FGF (XeFGF), is a maternal transcript in Xenopus embryos and
contains a known signal sequence (Isaacs e( al., 1992).
Androgen induced gmwth factor (AIGF, FGF-8) was originally identified as a
growth factor in a mouse mammary carcinoma cell line (Tanaka et ai, 1992). Fgf-8 is
differentially spliced to produce 8 different isoforms in the mouse and 4 different
isoforms in the human. The differential splicing is due 10 the presence different amino
lerminal exons (Gemel et al., 1996).
Glia-activating factor (GAF), a protein known for its ability to promote glial cell
proliferation, was the tenth member of the FGF family to be cloned (Miamoto et al.,
1993). Like other FGFs, FGF-9 has demonstrated transforming ability. When
transfecled into mouse BALB13T3 cells, the cells demonstrated Ihe ability to grow on soft
agar, and increased saturation density. When the transfonned cells were implanted inlo
nude mice, tumors fonned. FGF-9 is expressed in human glioma lumor as well as
stomach carcinoma cell lines (Matsumoto-Yoshitomi et ai, 1997). FGF-9, like FGF-l
and FGF·2. doesn'l contain a conventional signal sequence that is cleaved prior to exiting
the cell (MiamOlO et al., 1993). The Xenopus homologue of fgf-9 has been cloned. It is
93% identical to the mammalian gene, suggesting an important role in both species (Song
and Slack, 19%).
Fibroblast growth factor 10 was originally cloned by Yamasaki et al., 1996. It
has been mapped to chromosome 5p 12·p13 (Emceo et aI, 1997) and was discovered due
10 its similarity to Fgf·7, and originally named Kgf.2. However, FGF·IO doesn't appear
to have the same function in wound repair as FGF-7. Fgf-IO mRNA is relatively
abundant in mouse lung, sk.in, brain. and Ileart and Ilas been sllown to be repressed in
fibroblasts by transforming growth factor·~ CTGF·P) and tumor necrosis factor.o(l (TNf.
aJ (Beer er aI., 1997). FGF·IO Ilas displayed mitogenic activity in fetal rat keratinizing
epidermal cells. but not in Nnt/3T3 cells or fibroblasts (Emoto et ai., 1997).
1.2.1 The FGF Homologous Factors and FGF-15
Recently, four genes encoding FGF homologous factors (/hi) Ilave been cloned
(Smallwood et al., 1996). They were originally cloned via random eDNA sequencing.
data base searches and degenerate polymerase chain reaction (PeR). FHFs possess 58-
71 % amino acid identity to eacll otller. but less than 30% identity 10 other FGFs,
therefore they are thought to be a sublineage of the FGF family, and have been named
FHF-1 (FGF-12), FHF·2 (FGF-13). FHF-3 (FGF-II) and FHF4 (FGF·14). They are
expressed in the developing murine and adult central and peripheral nervous system as
well as heart and connective tissue (Hartung er ai., 1997). Human/gf·l J and/gf·12 have
been mapped to chromosomes 17 pl2 and 3q28.q29, respectively (Verdier et ai, 1997).
The final FGF identified thus far has been named FGF-! S (McWhiner et al..
1997). It was discovered via subtractive cDNA cloning to identify targets of
heterodimeric transcription factors Pbx! and E2A. FGF·IS yields a 15·30% homology to
other FGFs within the 120 amino acids conserved region and does contain an amino-
terminal signal sequence indicating thaI it is secreted. like other secreted FGFs, FGF·15
was able to transform 3D cells via soft agar colony fonnation and focus fonnation
assays. but did not display oncogenic activity. Fgf.15 is expressed in murine
neuroecuxlerm shortly after neurulation and is contained mostly within the nervous
system throughout development (McWhirter et 01. 1997).
1.2.2 The FGF Receptor Family
FGF binds two classes of cellular recepcors. a high·affinity tyrosine kinase
receptor (FGFR) and a low affinity heparin sulfate receptor. The high affinity receptors
appear to be most important foc carrying out FGF signal transduction and will be
discussed further.
There are four /gf rec:c:pcor «gfrI4) genes, which are alternatively spliced to
create several isofonns of each receptor. The/rfrl was initially described as a fms·like
gene (jIg) (Ruta et 01. 1988). FGFRI binds FGF·I and FGF-2 with high-affinity (Diollne
et al.• 1991). FGFRl was originally named bacterially expressed kinase (bek). and binds
FGF·I. FGF-2 and FOF·3 with high affinity (Dionne el al.• 1991. Mathieu et of., 1995).
FGFR3 is also known as chicken embryo kinase-2 (CEK-2) and binds FGF-I and FGF·2
with high affinity (Keegan et af.. 1991: MoUhieu et al.• 1995). The final FGFR, FOFR4
was discovered by Michael et 01., 1992, and binds FGF-I with high affinity. but not FGF-
2 (Mathieu eral.. I99S).
FGFRs are tyrosine kinase receptors. which possess an external domain with three
immunoglobulin· like regions (lg loops) and a hydrophilic "acid box" between the first
and second Ig loops. a transmembrane domain. a juxwnembr'ane ~gion and an internal
tyrosine kinase domain. A high affinity interaction between FGF U1d FGFR is facilitated
by heparin. The ligand binding activa1eS dimerization of the recept:or and
au[ophosphorylation. whereby the tyrosine kinase of one receptor molecule phosporylates
[he other. This initiates signal transduction pathways within the cell.
Differential expression of receptor isofonns and differing affinity of FGFs to
FGFRs leads [0 a complex pattern of receptor activation and signal transduction within
the developing embryo and adult organism.
1.3 Xenopus laevis Development ... Model System
For obvious ethical and logistical reasons, it is not possible to use humans for
developmental research of the nature being studied here. Development of many species
has been studied over time, however a select number of animal species have become
common experimental models due to various favorable characteristics. The mouse. for
example. is a common mammalian model. However for our ~search Xt!tlOpUS la~vis. the
African clawed·loed frog, is the model system of choice. This species offers many
advantages over mammalian models and it has been shown that the regulatory molecules
and pathways of development are highly conserved throughout vertebrate spe<:ies
(reviewed by Dawid. 1992). Therefore. even though amphibians and humans are quite
far apan on the evolutionary scale. basic: observations made about X~nopus development
are usually directly applicable to humans.
X~nopus faevis is an ideal model system to study development for several reasons.
Firstly. females may be injected with chorionic gonadotrophin to induce ovulation within
twenty-four hOUTS. Hundreds of eggs are laid at one time. enabling one to obtain a great
amount of material for experimentation. Then. the eggs may be: fertilized externally and
they develop synchronously so that the exact time of fertilization is known and they are
easily manipulated throughout development. Due 10 lhe nature of mammalian
reproduction. only a small number of offspring are available per female. Also. Xenopus
embryos are large (I-2mrn diameter). making them favorable for microdissection and
microinjection experiments. Finally. due to decades of research. there is already a vasl
amount of information available about X~nopw development.
1.4 Early Xenopus Development
As previously mentioned. X~nopw has become a model system for studying
vertebrate development. Landmark. experiments with X~nopu.J date back. 70 or more
years. The purpose of lhis section is to describe: the: current understanding of early
Xenopus development as well as experiments that have led researchers to this
understanding.
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1.4.1 Fertilization to Metamorphosis
Xenopus laevis reproduce via external fertilization. as previously discussed. At
fertilization. a rotation of the outer membrane ofthc zygote occurs (cortical rotation). and
the dorsa-ventral poles of the embryo arc determined. The point opposite sperm entry
becomes the dorsal pole (reviewed in Gilbert. 1994). The darkly pigmented. upper half
of the embryo is termed the animal half. and the lighter. yolty bottom half is the vegetal
half. The developmental stages of Xenopus have been given a numerical value such that
they may be compared (Figure 1.1). (Nieuwkoop and faber, 1967).
Fel1.i1ization initiates a rapid period of synchronous cell c1eOlvages. which are
cellular divisions without overall growth. After 12 cleavages. the embryo reaches the
blastula stage (5 hours post fertilization. stage 8), named so due to hollow cavity within
the center of the embryo. the blastocoel. At this point. the embryo is composed of two
distinct cell types, the upper animal cells containing the presumptive ectoderm and the
lower vegetal cells containing presumptive endodennal cells (Figure 1.2).
It is known that embryonic development initiates the fonnation of three basic
germ layers. The outermost ectodermal layer forms the skin, nervous system and sense
organs in adults. The innermost endoderma1 layer will fonn the lining of the digestive
system and associated organs such as the liver and pancreas. The middle layer is the
mesodermal layer. It will form the skeletal, circulatory, excretory and reproductive
system in adults. A diagram of the developmental fate of the three germ layers is shown
in Figure 1.2.
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Figure I 1 The Stages of Xenopus laevis Development (Reproduced from Wolpert el al.,
1998).
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Figure 1.2 Fate Map of the Developing Xenopus Embryo.
Up until blastula stage, there is only presumptive ectodennal and endodennal
tissue present. The mesodennal tissue is fonned later. The fonnation of mesodennal
tissue, mesodenn induction (MI), is a complex process whereby cells composing the
equatorial ectodenn of an embryo are acted upon by molecules (induced). These
molecules are released from adjacent equatorial vegetal cells. Thus, a band of
mesodennal cells is fonned at the equatorial region of the embryo. The molecules that
induce the fonnation of mesodenn. mesodenn induction factors. are of great interest to
researchers in the field. They will be discussed funher later.
Gastrula is the developmental stage directly after blastula stage. An embryo is in
gastrula stage (stages 10-13) from 11-14 % hours post fenilization. This stage is named
so due to the major cellular movements that take place. tenned gastrulation. During
gastrulation, the mesodennal tissue migrates upwards along the ectodennal tissue such
that they lie adjacent (figure 1.1). At this point the dorsal-ventral axis is detennined.
13
Neural induction is me second major induction event to take place in me
developing embryo. Neurula stage (stages 13·19) occurs between 143/4 and 20 hours
post fertilization. Neural induction is the process whereby the mesodermal tissue releases
molecules onto the adjacent ectodermal tissue to induce me formation of the nervous
system. Spemann organizer (5.0.) tissue (a region of dorsal mesodermal tissue) is
thought 10 be responsible for neural induction as well as mesodermal patterning. S.O.
tissue is thought to release inducing factors onto overlying ectodermal cells, changing
their developmental fate and inducing them to develop into neural plate (reviewed by
Dawid. 1992). During neural induction the anterior-posterior axis is formed.
The next major stage after neurulation is organogenesis (stages 22-45, 1-4 days
post fertilization). During organogenesis, funher tissue differentiation occurs.
Differentiation is the process whereby the developmental fate of a cell is changed by the
stimulation of new protein species in a pattern different from that previously found in that
cell (reviewed by Slack. 1983). Cellular differentiation leads to the formation of muscle,
cartilage and neurons. This is the point at which major organs begin developing. The
next stage in Xt!nopw development is metamorphosis (stages 45-66. 5-60 days post
fertilization), whereby the tadpole develops into an adult frog (reviewed by Wolpert et
ai.. 1998).
Vertebrate development is a very intricate and complex process. The focus of this
study is the process of development during which the presumptive mesodermal tissue is
created. mesoderm induction. Therefore, this stage of development will be discussed
further in the next section.
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1.4.2 Mesoderm Induction
In 1971, Sudarwati and Nieuwkoop first described Xenopus mesoderm induction.
They conducted an experiment whereby the lOp quaner of the embryo (animal cap. or
animal explant) was cut from the Xenopus embryo. When Ute animal cap was cultured in
isolation. the tissue developed into ectodermal tissue. However when cultured adjacent
to vegetal tissue. it developed into mesoderm. It was thought that something within the
vegetal half of the embryo was inducing the ectodermal tissue to become mesoderm.
From this and other pioneering experiments, Slack and colleagues proposed the three-
signal model 10 explain mesodermal induction (Smith et ai., 1985; Dale et al.. 1989;
Smith and Slack. 1983; Slack and Forman. 1980 and Dale and Slack, 1987), (Figure 1.3).
The three-signal model proposed that mesoderm induction was the result of three
different types of mesoderm induction factors (MlFs) acting on the equatorial ectodermal
cells. Two MIFs were thought to be released from the vegetal cells. One signal was
released from the dorsal vegetal mass (named the Nieuwkoop center in honour of its
discoverer) to act upon the adjacent dorsal animal cells. while a second signal was
released from the ventral vegetal mass to act upon the ventral animal cells (Figure 1.3).
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Figure 1.3 The Three Signal Model of Mesodenn Induction (Reproduced from Slack ~t
al., 1987).
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The third signal was thought to act after the dorsal and ventral MlFs. This signal
was released from the Spemann organizer and resulted in a gradient of dorsalizing factors
from the dorsal equatorial region to the ventral equatorial region. This signal was
responsible for patterning of the dorsal-ventral axis (Heasman. 1997). 5.0. was
discovered by Spemann and Mangold (1924) for its ability to induce the formation of an
ectopic dorsal-ventral axis when transplanted into the ventral side of a gastrula stage
embryo. 5.0. itself was induced by messages from the Nieuwkoop center.
This model was widely accepted for years. and is quite accurate. The main fault
of the model is that it over-simplifies the phenomenon of mesoderm induction. The
current understanding is that there are more than three factors involved in mesoderm
induction. along with a host of competence factors and other response molecules.
Compelence factors are molecules that make cells able (competent) to respond to other
signals.
There is also evidence that MIFs act synergistically to induce mesoderm
formation. For ex.ample. TGF-13 increases bFGF's ability to induce muscle actin
expression (Kimelman and Kirchner. 1987).
The complete process of mesoderm induction is still far from being completely
understood. The current understanding of the factors responsible for mesoderm induction
will be described in the next section.
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1.5 Mesoderm Induction Factors
Generally. induction is the process whereby Ihe developmental fate of one cell
population is changed by signals released from anolher population. There are Ihree main
criteria used to identify mesodenn induction factors. Firstly, the factor must demonslrale
activity, that is. ability to induce animal cap tissue 10 fonn mesodenn in vitro. Secondly,
the factor must be expressed at the correct stage in development. Thirdly, if the factor's
activity is inhibited in vivo. there will be a disruplion of induction (reviewed by Slack,
1993).
There are Iwo main families of MIFs; the lransfonning growth faCior P(TGF·P)
family. and the fibroblast growlh faclor family. There are also several factors mat cannot
induce mesodenn fonnation memselves, however they may complement or impede the
actions of MIFs. As described in the three-signal model, there are two major groups of
MIFs. dorsal and ventral. The two classes of MIFs interact closely in vivo, bUI for
simplicity, they will be discussed separately in the following sections.
1.5.1 Dorsal Mesoderm Induction Factors
When ultra-violet light is applied to the vegetal side of the embryo at fenilizal.ion.
it is effective in blocking the dorsal pathway (Holwill t!r ai., 1987). This blockage is
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caused by a disruption in lite cortical movements lItat occur at fertilization. thereby
preventing the dorsalizing factors from being in the correct location to act upon
competent cells during gastrulation. Therefore. using UV irradiated embryos is an
effeclive means of examining molecules expressed in early embryos lItat are able 10
rescue the ventralized phenotype (dorsalizing faclors).
Several TGF·~ family members appear to play an important role in dorsal
mesoderm formation. Two important faclors are activin A and vegetally localized faclor
Vgi. VgI mRNA is expressed maternally in vegetal cells in an inactive fonn (Rebagliali
er aJ., 1985; Weeks and Melton, 1987). Injection of a mUlant ligand lItat appears to
selectively block Vgl signaling results in Xenopw embryos thaI lack dorsal mesoderm
and axial structures (Joseph and Mellon. 1998). However, lite method of VgI activation
has yel to be elucidated.
Activin A is the most potent mesoderm inducer in !he TGF·j! family. It is able 10
induce the formation of different forms of mesoderm in animal cap explants. in a
concentration dependenl manner. When tissue is exposed to 0.1-2.0 nglml of activin.
ventral mesoderm is induced. However at concentrations of 1.64.0 nglrol. intermediate
mesoderm is formed. and at concentrations above 4.3 ngfm1. the tissue becomes dorsal
mesoderm and demonstrates organizing ability (Cooke. 1989; Green et ai., 1992).
There are several receplOrs known to interact willt various TGF·~ family
members. Different receptors have been shown to bind more than one ligand. similar to
FGFRs. Dominant negative forms of lite aetivin type 0 receplor reduce mesoderm
formation in the embryo (Hemmati-Brivanlou and Melton. 1992).
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It has been shown that activin and Vgl induce expression of mix2, a homeobox
transcription factor (Vize, 1996). The signal transduction pathway leading to mix2
expression has been elucidated (Figure 1.4), (Chen l!l ai., 1996). Activin activation of its
type I receptor leads to phosphorylation and activation of SMAD2 (mothers against
decapenraplegic). This activated protein then localizes to the nucleus and binds to the
forkhead activin·sensitive transcription factor (FASTI), inducing mix2 transcription
(reviewed by Heasman, 1997).
Another signal transduction pathway that is thought to be imponant in dorsal
mesoderm induction is the p.catenin pathway (Figure 1.4). p.catenin is a membrane
associated and cytoplasmic protein which, when depleted in Xenopus embryos, causes
severe ventralizing effects (Heasman et at., 1994).
It has been proposed that activation of a cell surface receptor homologous to the
Drosophila frizzled receptor (Xfz), results in activation the Xl!nopus homologue of the
Drosophila disheveled gene (Xdsh). In tum, XDSH inhibits glycogen synthase kinase
(GSK3). Normally GSK3 phosphorylates p.catenin and initiates its degradation.
Therefore. inhibition of aslO allows p.catenin to be present in the cell to dimerize with
the transcription factor XTcf-3. The heterodimer is thought to localize to the nucleus and
initiate transcription of specific genes involved in perpetuation of the dorsal mesodenn
induction pathway, such as goosecoid and siamois. This is the proposed pathway.
however the exact mechanism is not known (reviewed by Heasman, 1997).
It was previously thought that Xwnt acted as a ligand for Xfz. Xwnt has a
proposed involvement in ventral mesodenn patterning (Christian and Moon, 1993). Gain
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Figure 1.4 Proposed Dorsal Mesodermpalhway. (B) The Activin Pathway Induction Pathways. (A) Xwntl~-Calenin
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and loss-of-function experiments by Happier and colleagues suppo" a model in which
Xwnt·8 (a member of the Xwnt family) induces expression of genes involved in
specification of both ventral and somatic mesodenn (Hoppler et 01.• 1996). Studies
donewllh Frzb (a membet of the Frz family) indicate that it is a soluble ptotein expressed
in Spemann otganizer and is involved in dotSalization of Xenopus embryos. It is now
thought thaI Frzb binds and inactivates Xwnt-8.lhus preventing Xwnt-8 ventral signaling
in dorsal tissues (Wang et ai.. 1997). However. further study must be done in this area
1.5.2 Ventral Mesoderm Induction Factors
The bone morphogenic protein (BMP) members of the TGF-/3 family are thought
to be important factors in the formation of ventral mesodenn in Xenopus embryos.
Bmp2. bmp4 and bmp7 mRNAs are prescnt in the early =mbryo due to transcription of the
maternal genes (Koster et of.• 1991; Nishimatsu et 01., 1992; Dale er 01.• 1992; Jones et
al., 1992). BMP4 is first observed al gaswla stage in animal and vegetal equatorial cells.
Expression experiments with BMPs in the mesodennal tissue demonstrated induction of
ventral mesodenn. such as mesenchyme, blood islands and muscle in Xenopus (reviewed
in Heasman. 1997). Inactivating this pathway causes dorsal mesoderm to form instead of
ventral mesodenn. Dominant negative mutants of BMP receptor results in restoration of
axial structures in j3·Catenin depleted embryos (Wylie et al. 1996). Distinct roles for the
three BMPs in mesodenn induction have not yet been delineated.
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1.5.3 The Role of FGF in Mesodenn Induction
Currently. five FGFs have been cloned in Xenopw Jaevis. They are; FGF-I FGF-
2, FGF-3, eFGF and FGF-9. FGFs 1-6 (human FGF 4-6 were used) along with XeFGF
have demonstrated ability to induce mesoderm formation in animal cap explant
experiments (reviewed by Slack. 1994, and Slack el al.• 1996). Ability 10 induce
mesoderm in explants. however does not indicate that they do induce mesorlerm in vivo.
As previously mentioned. the inducer must be expressed at the correct time in
development. it must be active at that stage and loss of function must have a negative
effect within the embryo.
Dominant negative FGF receptor (XflJ) studies in which mRNA for an inactive
receptor is injected into Xenopus laevis indicate that FGF is an important factor in
mesoderm induction (Amaya, 1991). Since the FGFR dimerizes when activated. if most
of the receptors are inactive. they will bind the nonnal FGFR making it impossible for the
receptor to carry out the signal.
FgfrJ is expressed throughout development (Musci er al.• 1990; Friesel and
Dawid. 1991), mostly within the equatorial region (Gillespie er al., 1989). XFD embryos
develop abnonnally, having reduced levels of mesodennal derivatives. they appear
anteriorized with reduced posterior structures (Amaya, 1991). This infonnation does not
indicate which FGF(s) are active at this stage in development, however.
Studies with XFGF-2 demonstrate that it is able to induce mesodenn fonnation in
blastula stage animal cap explants (Slack er al .• 1987). It is present in the embryo at
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inlennediate levels during mesodenn induction. As prevkxlsly mentioned, the secretion
~hanismof FGF-2 is yet unknown, as it doesn't have a common signal sequence.
XeFGF is thought 10 be involved in mesodenn induction in vivo. It is expressed
maternally and zygotically at peak levels in the gastrula stage embryo. The protein is
presenl in vivo at sufficient levels to induce mesodenn and it is efficiently secreted from
the cell (Slack et ai., 1996).
The role of FGF in mesodenn induction may be further understood by elucidating
the signal transduction pathways initiated by FGF during this time period. Discovering
the genes activated by these pathways will lead to a further understanding of the process.
The purpose of the following sections is to outline the known pathways and genes
activated by FGF during mesodenn induction.
1.5.4 The Role of FGF in Actlvin Induced Mesoderm Formation
It has been proposed that FGF plays a role as a competence factor for other MlFs
during mesodenn induction (reviewed by lsaacs, 1991). Equatorial cells are only able to
respond to mesodenn induction signals at a select time during development. XFGF·2 has
been suggested as a competence factor for activin during mesodenn induction (Cornell
and Kimelman, 1994; LaBonne and Whitman 1994).
Animal cap explants containing dominant negative FGFR. c-RAS or c-RAF were
treated with activin. The defective members of the FGF pathway inhibited expression of
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some mesodermal marleen, such as muscle actin, Xbra, Mix! and Xnot which arc:
nonnally expressed in response to activin treatment. The expression of other genes,
including head organizer genes goosecoid and Xlim-! was also reduced (Cornell and
Kime1man, 1994: LaBonne and Whitman 1994). The 'trunkless head' phenotype was
created, similar to that observed in dominant negative FGFR embryos without activin. It
has been proposed that FGF may act within the equatorial region of Xenopus embryos as
a competence factor for mesoderm induction by activin·type signals (Cornell er al.,
1995).
1.6 FGF and Signal Transduction
Signal transduction pathways initialed by FGF within activated cells have not yet
been fully elucidated. However, FGF has shown 10 activate several well-known
cascades. As mentioned previously, FGF binds and aetivatc:s its cell surface receptor.
The activaled receptor then undergoes dimerization and autophosphorylation on tyrosine,
which is a high-affinity binding site for src·homology 2 (SH2) containing proteins. 11le
activated receptor possesses tyrosine kinase activity and therefore phoshporylatts specific
molecules. This results in the initiation of a signal transduction cascade within the cell.
FGFR I has been shown to act through at least lhree different signaling pathways:
phospholipase C gamma 1 (PLCyl), Ras, and phosphoinositide 3' kinase (P13'K) (Ryan
"
e.t 01., 1998). The three general pathways will be reviewed in the next sections (Figure
1.5), followed by the specific pathways activated by FGF in Xenopus embryos.
1.6.1 The Phospholipase Cy1 Pathway
PLCyl is a signal transduction molecule which, when activated, initiates
hydrolysis of phosphatidylinositol 4,5- bisphosphate (PIP]) to diacylglycerol (DAO) and
phosphatidylinositol (IP]). DAG is a protein kinase C (PKC) activator. and IP] initiates
the release of cellular calcium stores. The second messengers activate several molecules
and thereby bring about the desired cellular processes such as transcription (reviewed by
Kamat and Carpender. 1997).
1.6.2 The RAS Pathway
The ras pathway has been well characterized for other growth factors, such as
epidermal growth factor (EOF) and platelet derived growth factor (PDGf). A similar
pathway is thought to be initiated by FOF. The pathway is activated by receptor
autophosphorylation. Phospho-tyrosines on the activated receptor bind the SH2 domain
of growth factor receptor binding protein 2 (GRB2). GRB2 is a cytoplasmic molecule
"
Figure 1.5 Signal Transduction Pathways Initiated by Various Growth Factors. (A)
PI3'K, (B) RAS, (C) PLe.
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associated with son of sevenless (50S), a guanine nucleotide exchange factor. Binding
of GRB2-S0S to the n=ceptor leads to Ras activation. R.as perpetUates the pathway via
subsequent activation and/or phosphorylation of c-Rae, mitogen activated protein kinase
(MAPK) kinase. then other kinases. which in tum travel into the nucleus and activate
other molecules. initiating transcription of desired proteins (reviewed in Lewin, 1994).
1.6.3 The Phosphoinosilide 3' Kinase Pathway
The last known signal transduction pathway initiated by FGF is the P13'K
pathway. This pathway plays various roles in many systems, including; cyloskeletal
rearrangemeRls, cellular migrations, mitogenesis, differentiation and protection from
apoptosis. PO'K phosphorylates hydroxyl groups of phosphotidylinositols on the third
position of inositol thereby activating inert membrane phospholipids and initiating a
signal transduction pathway. Many of the phospholipids involved in the PLCy pathway
may also be phosphorylated by P13'K.
The exact signal cascade in the P13'K is not as well understood as the others.
however. the understanding of the general mechanism are as follows. The p85 protein is
pan of PI3'K which binds active phosphotyrosine receptors via SH2. P13'K is also
activated by RAS proteins. P13'K in tum, phosphorylatcs various membrane
phosphoinositols which activote panicular proteins. Proteins activated by this pathway
include: protein kinase B (PKB or AKT), p70 ribosomal 56 kinase (p70S6''') and PKC.
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PKB activates glycogen synthase Dnase 3 (OSlO) in vivo. and is also thought to act
upstream ofp7oW' (reviewed by Vanhaesebroeck ~tal.• 1997).
1.6.4 Signal Tra....uction Molecules Activated by FGF in Xenopus
There are several components of the three fore·mentioned signal transduction
pathways. as well as molecules of other pathways that ate known effectors of FOF in
Xenopus embryos. There is also evidence of cross talk between different pathways. It
has been shown that the PlCyI pathway activates mitogen-activated protein (MAP)
kinase from the Ras pathway in FOF·2 treated X~f10P/LJ animal cap cxplants (Rose and
Busa. 1998).
Activated FGFRI forms a complex with at leasllen other proteins (Ryan ~t al.
1998; Figure 1.6). The FGFR I associated proteins include: PlCyl. NCK. SOS. GRB2.
Ras-GTPase associated protein (ras-GAP), pBS of PD'K and SHP2 as well as 3 NCK
associated proteins (NAP65, NAPS I and NAPI23).
Several of the FGFR I binding proc:eins are known effectors of transduction
pathways initiated by growth factoD and cytokines in other models. For example, GRB2
and SOS bind when stimulated by EGF and are thought to signal via a ras dependent
pathway as in Figure I.S (Vidal ~r al.• 1998). SHP2 (tyrosine phosphatase) and p8S of
PI3'K co-immunoprecipitate in response to interJeukin 3 stimulation (Craddock and
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Figure 1.6 FGFR 1Associated Proteins A. Schematic diagram of proteins isolated with
activated FGFRI dimer. along with known effectors of the FGF induced signal
transduction pathway. B. Table of FGFRI associated proteins.
Welham. 1997). GRB2 and ras..QAP co-precipiwe wilh insulin receptor. and are lhought
to internet in lhe RAS pathway (Hwang et al., 1997).
NCK is an oncoprotein and mediator of several mitogenic effects. composed
primarily of SH1 and SH3 domains and phosphorylar.ed on tyrosine while associated wilh
FGFR1 (Ryan elal. 1998). The function of NAPs is yet unknown.
Through loss of function assays, it has been demonSU'3led that RAS. RAF. and
MAP kinase are all needed to perpetuate FGF signaling (LaBonne el aJ .• 1995; Kim el aJ,
1998). In panicular, dominant negative RAF blocks the mesodenn inducing activity of
FGF (Demo et aJ., 1994). In other experimenl~, PKC inhibition has also shown to inhibit
mesoderm induction via FGF (Gillespie er aJ., 1992). PLCyl was shown to be associated
with FGFRI during mesoderm induction in Xenopw (Ryan and Gillespie, 19(4).
1.7lmmediate-Early Ge...
Immediate-early genes (or early response genes) are the. first genes to be
transcribed differentially in response to growth factor treatment of a cellular population.
In order to classify a gene as immediate-early. it does not require de novo protein
synthesis for transcription and is usually eltpressed within thirty minutes of mitogen
action. Many early response genes are transcription factors, receptor molecules,
transmembrane proteins Of secretory molecules. Conversely, gene uanscription may be
tenninated by growth factors.
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The transcription factors induced as immediate-carly genes, in rum. initiate (or
lerminate) transcription or activation of new genes and proc:eins, which carry out the
desired cellular response. For example, the mix/ homeobox transcription factor is an
immediate-early activin·induced gene (reviewed by Godsave and Gillespie. 1991).
Unde~tanding gene regulation via the signal transduction cascades is important for
elucidation of the mechanisms whereby FGF elicits cellular actions. However very few
FGF response genes have been identified and characterized, a small number of genes
activated by FGF have been elucidated.
Mesoderm induction via FGF is inhibited by dominant negative mUlant c.jun
(Dong er €Ii., 1996). C·jun is an immediate-early oncogene and transcription factor,
which forms homodimcn and heterodimers with c·fos. The dimer arrangement
composes activator pnxein I (API). Funher studies have shown that c-fos is also
necessary for mesoderm formation in XenoplLJ via FGF, therefore it is Ihought that the
heterodimcr API is a downstream target ofFGF. (Kim er ai.• 1998).
The Xenopw homologue of the Brad1yury (Xbra) gene is a DNA binding proc:ein
upregulaled by FGF. Xbra is able to induce mesoderm fornwion: venlral mesoderm at
low concentrations and intermediate mesodenn at higher concentrations (Cunliffe and
Smith, 1994). Xbra and eFGF are able to activate transcription of each other and are
thought to act in an autocalalytic manner during mesoderm induction (Isaacs el al., 1994).
An immediate-early gene upregulated by FGF-induced differentiation in rat
hippocampal neuronal cells has been cloned, named pip92 (Chung el €II.• 1998). The
human gene is ~arly FA responsive 101 (err /OJ). ETR 10I1P1P92 contains 2 nuclear
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localization signals. and a region of similarity to JUNs and therefore was originally
proposed to be a transcription factor. however its function remains unknown (Shimizu et
al., 1991). The serum response elemenl (SRE) of the pip92 promotor is aclivated in
response to FGF via the transcription faclor ElklrrCF (a member of the Ets family of
transcription factors). Elk is activaled by phosphorylation via MAPK dependem and
independent pathways the detailed mechanism is as yet unknown (Chung et al .• 1998).
Another early response gene, upregulaled by FGF-I, has been namedftzk for ,EGF
i,!!ducible !inase. It was identified by targeted differential display in mouse NIH/3T3
cells and is also induced in an immediate early fashion in response 10 FGF·2. FNK is a
member of the polo subfamily of serineJthreonine kinases (Donohue et aI., 1995).
A gene cloned in our laboratory that is upregulaled in response 10 FGF treatment
of Xenopus animal cap explants is ~arly response 1 (ERI) (Paterno et ai., 1997). ERI
contains IWO nuclear localization signals, a putative DNA binding domain, and has
demonstrated transcriptional activity. It is thought that ERI contains a negatively
regulating sequence that. when removed allows it to activate transcription. Therefore. the
novel gene, erl may act as a transcription factor during mesodenn induction in Xenopus
laevis (Palerno et ai., 1997).
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1.8 Purpose of Ihe Project, Hypothesis and Goals
As reviewed in previous sections, FGF appears to playa significant role in normal
animal development. especially during mesoderm induction. It is therefore imponant to
elucidate where, when and how FGF molecules elicit their action within various tissues.
The area of FGF research that I have chosen 10 study is the molecular mechanism
of mesoderm induction by FGF, in panicular, differential expression of immediale-early
genes in response to FGF treatment. As previously described, mosl immedialc-early
genes differentially expressed in response to growth factors are transcription factors.
These transcription factors. in tum. induce other genes required to perpetuate the
anticipated response.
The early response gene ER I was cloned in this lab via differential display
technology. There were four OIher genes that appeared to be differentially expressed in
response to FGF treatment in the same differential display experiment. The goal of this
study was to characterize the other four genes isolated from the differential display gel.
This was done by detennining the nucleotide and potential amino acid sequences of the
cDNA fragments, searching for potential functional domains. and examining expression
of the representative genes in response to XFGF-2 and throughout development.
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CHAPTER 2
Materials and Methods
2.1 Plasmid Prep.ratioDS
The purpose of this procedure was to isolate plasmid DNA from bacterial cells on
a large scale for funher analysis of DNA inserts. 'The plasmid was isolated from bacterial
cells. then purifted by cesium chloride gradient as described in Sambrook. Fritsch and
Maniatis. 1989. This procedure is also known as a "maxi prep".
2.1.1 Materials
Most of the materials required for the plasmid prep were supplied from DOH Inc.
and include:: agar. glycerol, butanol. peptone from meal (pepsin digested), eJtU'aCt of yeast
powder. and sodium chloride. The organic: chemicals. including isopropanol. phenol.
chloroform. isoamylalcohol. and ethanol were purchased from Fisher ScientifIC.
Ampicillin was obtained from Sigma. Cesium Chloride was purchased from Gibco ORL.
and Ethidium Bromide from BioRad. Boeringer Mannheim supplied the RNAse A.
"
2.1.2 Methods
Glycerol slOcks had been made previously from bacterial colonies grown on
50Ilg/ml ampicillin in luria broth (LB) (lOgII peptone, SgII eXlraCI of yeast powder. JOg/l
sodium chloride). agar plales. A colony was removed from the plate and grown in LB +
ampicillin media at 37cC 16 hours, then 800u1 of culture was added 10 200J.11 glycerol.
Stocks were stored at _70°C until needed.
The glycerol stocks were removed from _70°C and streaked on LB agar plales
containing 751olg/ml ampicillin. The bacterial cells were allowed to divide 14-16 hours at
37°C. Distinct colonies were removed and restreaked. as above. A pure colony was then
chosen from the restreak plate. and used to inoculate 500 ml of LB broth containing
751-1g/m1 ampicillin. The culture was grown 14-16 hours with shaking at 230 rpm, 37"C.
The culture was divided into two pre-<:ooled 250m! bottles and was incubated on
ice for 15 minUies and centrifuged at 4000rpm for 5 minutes. The supernatant was
poured off and bacterial pellet was resuspended.. with pipeuing. in 13ml of plasmid prep
solution # I (see Table 2.1 for compositions of Plasmid Prep Solutions). The solution was
transferred to a SOml Oakridge tube and allowed to sit at room temperature for S minutes.
Next. cells were lysed in 26 ml of plasmid prep solution 12. on ice, for S minutes. 13 ml
of plasmid prep solution "3 (at 4°C) was added to precipitate protein and chromosomal
DNA. Solutions were left on ice for 10 minUles. then centrifuged at 12000rpm for 10
minutes.
The supernatant was carefully pipened into a new Oakridge tube and 60% of
initial volume of isopropanol was added. Precipitation of the plasmid DNA occurred at
room lemperature over S minutes. The DNA was pelleued by centrifugation at 8000 rpm
for 10 minutes. The supernatant was discarded and the pellet was resuspended in 3ml of
solution #4. The volume was made up 10 4.2 ml, and 42+aJ of IOmglml RNAse A was
added to digest RNA. 4.1g of cesium chloride was dissolved in the solution. along with
O.5ml of IOmg/ml elhidium bromide 10 aid in visualization of the DNA. Any remaining
lipids or proteins were removed by centrifugation at SOOOrpm for 10 minutes. and the
preparation was injected into a quick seal tube. The tubes were balanced. heat-sealed
(one per preparation), and centrifuged at 4S000rpm, 20°C, under vacuum, for 18·20
hours.
Table 2.1 Contents of Plasmid Prep Solutions
Solution Number
Glucose
1M Tris. pH 8.0
O.5M EDTA, pH 8.0
IO%SDS
IONNAOH
SMCH1COOK
Glacial Acetic Acid
Tris, pH 8.0
EDTA.pH8.0
n
O.OSOM
O.02SM
O.OIOM
O.OO2M
3M
11.5%
O.OSOM
O.OOIM
The tubes were carefully removed from the rotor and the plasmid DNA (visible as
a dark band. but fluorescent under ultra violet light) was removed with a l6-gauge needle
into a 15ml polypropylene tube. The ethidium bromide and other products were
extracted from the DNA with water saturated butanol. The extraction was conducted 5-8
times with equal volumes of butanol until the aqueous layer appeared colourless to very
pale orange. The aqueous phase was then diluted 1:3 with plasmid prep solution #4 and
extracted twice with equal volume of phenol:chloroform:isoamylalcohol (25:24: I).
Precipitation of the plasmid DNA was conducted with 10% 3M sodium acetate
and 2 times volume of 100% ethanol for I hour at room temperature. The precipitate
was centrifuged at 8000rpm for 30 minutes. washed with 70% ethanol (EtOH). dried
under vacuum and resuspended in 200ul of plasmid prep solution #4. The concentration
and integrity of the plasmid was tested by running Iul of sample on a 1% agarose gel.
The remainder was stored at 4°C.
2.2 Sequencing Plasmid DNA
The Chain Tennination sequencing method was used to sequence the DNA
fragments. which had been previously inserted into pCR 2.0 plasmid DNA at the multiple
cloning site. The basic method used in this procedure is as follows: A plasmid specific
primer was annealed 10 the plasmid. then extended with 17 DNA polymerase and
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nucleotides. including [al'Sl-dAllt. The reaction was terminattd at varying sites with
dideoxynucleotides and the reactions (one for each nucleotide) run on a sequencing gel.
2.2.1 Materials
The Sequenase Version 2.1 Sequencing Kit was purchased from Amersham Life
Science. The following reagents were supplied with the kit; O.IM Dithiothreitol. ddA.
ddC. ddG and ddt Tennination Mix. Stop Solution. Enzyme Dilution Buffer. Sequenase
Buffer. and Sequenase 17 DNA Polymerase. The [al'SJ~TP was supplied by Mandel
Scientific. NaOH was purchased from IT Baker and Company. EDTA (CloHl.OaNa~
2H~O) was purchased from Fisher Scientific. Primers SP6. T7. pCR·T and pCR-SP were
synthesized by Gibco BRL (see Table 2.2).
2.2.2 Methods
The following protocol was used to sequence the insen. DNA from both ends. lfM
(IOIag) of plasmid DNA was added to 4d of 2N NAOHI'2mM fDTA and 8Jd of distilled
water. The mixture was incubated al 37"C for 30 minutes to denature the DNA. The
sample was then precipitar.ed with 2.2p.I 3M sodium acetate pH S.2 and ~ of 100%
ethanol at ·70"C for 20 minutes. The precipitate was centrifuged at 4°C. for 20 minutes.
The DNA was then washed with 70% ethanol. centrifuged again, dried under vacuum. and
resuspended in ISIll distilled water.
J9
Table 2.2 Base Pair Sequences of Primers used for Sequencing and PCR
Primer Name Primer Sequence S' - 3'
5P6 AT TI'AGGTGAC ACT ATA
n AT ATACGAcrCACf ATAGGG
pCR-5P ATCCA CTA GTA ACG ace GCC
pCR-T AGCGGCCGCCAGTGTGATGG
5"MEFB CCACACTATcrCTATTCC AG
3'MEFB GGT AAGTATTGAAGT AGCAC
514-1 OCT ATAGAG ACO TAT ATGAC
514·2 CAG TOT ACT GGA MC TCC AO
ChemR-I OM GAT GCC CAG CAG TAA CG
ChemR-2 TGGCAA AGAOCTTGCITAAC
5175' GCCTAA ATe ATACATCTGCC
5173' CIT crA GCA GGC ATG AGT at
5305" AACcrGATGATACfCAGT AC
5303' ATCAATATCTGG TCG CAT AG
T3 ATT AACCCTCACTAAAG
PACT2-for GTTCCAGATTACGCT AGCTTGGG
PACT2-rev CAC AGT TGA AGT GM err GCG G
8858 TCC AGGGTA AM AGCAAAAGA AITC
8861 GCC TOG ITA Am CCA AGe TGA AIT C
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The annealing reaction Wti carried out separately for each primer. the 5' plasmid
primers used wcre SP6 and peR·Sf (a primer designed to anneal very close to the S· vector·
inscn join), and the )' primm used were n and PCR-T (again, designed due to close
proximity to the )' join). To 71ll of denalured DNA, 2ul of Sequencing reaction buffer. and
1p.1 of IOnglp.1 primer Wti added. "The mixNre was denatured aI 65°C for 2 minutes and
then allowed 10 cool slowly in a watc:r bath to 3O"'C (approxirnatcly45 minutes).
Next, the sequencing reaction was pc:rfonned. To the annealed DNA. the: following
components were added:
1p.1 Dithiothreilol
2",1 labeling mix (previously diluted 1:5 with waler)
1.75p.1 .sequencing dilution buffer
1p.1 )£XXluCi (auSl-dATP
O.25p.1 Sequenase enzyme
The components were mixed by pipetting and allowed to incubate 5 minutes at room
temperature. O.6IU mictocenuifuge tubes were labeled for each nucleotide A. C. G. and T.
Previously, 2.5Ill of dKiioxy4eml.inal mix were added to the appropriale tube. the tubes were
heated 10 )7"C for 2 minutes. 3.S~ 0( sequencing reaction were added to each tube, and
reaction was a11o~ to proceed for 5 minutes.. The reaction was Slopped with 4pl of stop
buffer. The samples were stored at·2O"C uOitil sequencine gel was run.
"
2.3 Polyacrylamide SeqU<Dcing Gel Preparalioo and EIectropbor<sis
2.3.1 Materials
Materials for polyacrylamide gel electrophoresis. such as the gel chamber and
support. along with the acryJamide solution and TEMED <N.N.N'N'
Tctramcthylethylenediamine) were purchased from BioRad. Ammonium Persulfale; was
obtained from BRL (Bcthesdia Research Labs). Tris. Boric Acid, EDTA. Urea. Glacial
Acetic Acid. and Methanol were purchased from Fisher Scientific.
2.3.2 Methods
A 6% polyacrylamide sequencing gel was used 10 run the sequencing reactions. The
gel plates and chambers were cleaned thoroughly with detergent and ethanol. prior 10 use to
eliminate bubbles during pouring of the gel due to din and dust. The appanhLS was
assembled according to manufaetute's insuuctions.
The sequencing gel mix was made with:
40mlwater
1000IOXTrisIBoricacidlEDTAbuffer
48gUrea
ISml4O% acrylamide solution (1:19 bisacrylamide:acrylamide)
The urea was dissolved in solution by swirling flask containing mix~ under wann tap
water. The solution was then fillered using no. I Whatman filler paper and degassed under
vacuum. 4OIJJ.U of freshly prepared 10% ammonium persuJfale and~ of TEMED were
added to the gel mix to initiale polymerization. The gel was then pouted and allowed to
polymerize at 1east 2 hou~ befCR: running.
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The gel chamber was filled with ~.warmed (to approximately 4S°C) IXTBE
blJfft:r and pre-ron at 60 volts for 20 minutes to allow equilibration of ions. The 5eqUt:ncing
reactions wt:rt: denatured at ~9O"C for 3 minutes, tht:n 3ul of sequencing reaction was
loadt:d onto the gel. TIle gel was run at 60 volts unlilthe first, bromophenol blue dyt: front
had run to the bottom of the gel (approx. 2 hours). This was suffICient for sequencing from
the vector-insen join inward. The gel was run longer according to whc:re the: desired
sequence was located relative to the primer.
Aftt:r running, the gel apparaNS was disassembled. the gel was fixed with a 10%
methanoVIO% glacial acetic acid solution and dried under vacuum. The gel was then
pack.ed with X-ray film and developed after approximately 1~20 hours exposure.
2.4 Fertilization of Xenopus eggs
2.4.1 Materials
X~"OPW lanis were purchased from Nasco. Human Chorionk Gonadotrophin
and Cysteine were supplied by Sigma. NAM salts were purchased from the following
companies: NaCI (SOH Inc), KCI, Ca(NO:.h4H~, MgS04 7H~, EDTA (all from
Fisher Scientific), HEPES (Sigma Chemicals),
"
2.4.2 Methods
Mature eggs were isolated and anificiaJly fertilized as per Godsave et al., (1988).
Approximately 16 hours before eggs were needed, 7S0 I. U. of Human Chorionic
Gonadotrophin was injected subcutaneously into the upper hind leg of a female Xenopus
laevis.jusl above the cloaca. Within 12-18 hours, the female began to lay eggs, which
were collected on a petri dish.
Next, eggs were fertilized with sperm elttracted from a male testis. A male frog
was previously sacrificed, testes were removed and stored a 4°C in 1 X NAM (Normal
Amphibian Medium, see composition of the NAM solutions in Table 2.3: Slack. and
Forman 1980). Approximately I~ of testes were mixed with a large drop of distilled
water. The mixture was released by pipening over the prepared eggs. A period of len
minutes was allowed for fertilization 10 take place and eggs were covered in water. A
visible rotation of zygotes to animal (dark) side up indicated that the eggs had been
fertilized.
The embryos were dejellied in a solution of 2.5% cysteine. pH 7.9. The embryos
were swirled in cysteine for 20 seconds. then rinsed thoroughly with deionized water, II
per 200 embryos. Water was removed and eggs were submerged in NAMI20. First
cleavage begins 1-1.5 hOUr!! afterfertilization.
Table 2.3 Composition of NAM (Nonnat Amphibian Medium) used for X. LA~vis
Experiments.
lOX NAM Salts
cnuns/Ulft
--(iD lOX ......) (in IX soIutioD)
NaCI 65 110
KCL 1.5 2
Ca(NOl h4H2O 2.• 1
MgS047H20 2.5 I
EDTA (0.5M. pH 8) 2ml 0.1
Hepes (1M, pH 7.5) lOOmI 10
For 100 mI • IX Solutions
NAM(m1j NAMI2O(_1)
IOXNAMSalts 10 0.5
Gentarnycin 0.25 0.25
NaH2CO} 0.0
Sterile H2O 88.15 99.25
2.5 Microdisection and Treatment of Xenopus Explants
2.5.1 Materials
Recombinant XFGF-2 was expressed and purified according to KUllelman et al.
(1988). Bovine Serum Albumin (BSA) was purchased from Sigma Chemicals. Trizol
Reagent was purchased from Gibeo BRL.
2.5.2 Methods
Xenopus embryos were allowed to incubate in NAM!20 for approximately 5
hours at room temperature to develop to Stage 8 according to Nieukoop and Faber
Nonna! table of Xenopus Laevis, (1967). Once they had reached Stage 8, they were
transferred to a petri dish lined with 1.5% agar and filled with IX NAM solution. The
vitelline membrane was removed manually with forceps. and the top 'A of the embryo
(animal cap explant) was cut out using a tungsten wire needle. The explanlS were cut in
groups of approximately 20. The experimental set of embryos were placed in 201M of
NAM/2 + Imglml BSA containing 100 nglml XFGF·2 in a peui dish. The control
explants were treated with NAM/2 + Imglml BSA without XFGF·2. Treatments were
for 30 minutes. Explants were then pipelted into microfuge tubes, 0.5 ml of Trizol
reagent was added, pipetted and vortexed to homogenize tissue. then solutions were
placed at _70°C until the RNA extraction was perfonned.
Two sets of explanlS were cut to examine effectiveness of the FGF treatment.
One set was placed in NAM/2 + BSA and the other set in 1000glmi XFGF-2 in NAMIl +
BSA, and allowed to incubate 20-24 hours. The explants were then flooded with NAMIl
..
and observed for anolher 2-3 days. Induced explants appear balloon shaped after 2·3
days, large hollow balls with some grey tissue inside. Uninduced explants. however do
nOI change over the course of incubation, they remain as small dark grey spheres of
tissue.
2.6 Isolation of RNA from Xenopus embryos and explants
2.6.1 Materials
The Chloroform and Isopropanol were supplied by Fisher Scientific. Dielhyl-
pyrocarbonate (DEPC) was purchased from Sigma Chemicals, and RNA Guard from
Phannacia Biotech.
2.6.2 Methods
RNA was isolated from Xenopus tissue using the Trizol Reagent method of
extraction. The same volumes of reagents were used for 5 embryos or 20 explants. The
tissue was homogenized in 0.5 ml of Trizol reagent, as previously mentioned. At this
point, the homogenate was either stored at -700C or the extraction was conducted
immediately. If frozen, the samples were thawed at room temperature and then treated
as unfrozen samples.
Homogenates were incubated at room temperature for 10 minutes to allow
separation of nucleoprotein complexes. loo,.u of chloroform were added to extract the
protein. The tubes were vortexed for 10 seconds, then allowed to incubate for 10 minutes
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at room temperature. Samples were centrifuged for to minutes at 14000 rpm to allow
separation of layers. The upper aqueous layer was pipelted into a new tube and 250tll
isopropanol was added. The samples were vortexed for 10 seconds and incubated at
room temperature for 7·8 minutes to allow for precipitation of RNA. The samples were
then centrifuged at 4°C and washed with I ml 75% ethanol. The RNA was dried in a
dessicator under vacuum and resuspended in DEpc· treated water. O.SILI of RNA Guard
was added to help protect RNA from degradation. The integrity of the RNA was tested
by running 0.5111 of sample on a 1% agarose gel.
2.7 Isolation of Messenger RNA from Total RNA
Many of the gene products studied in this project were eltpressed at very low
levels. Therefore, for Northern blolting it was favourable to use polyA+ RNA instead of
total RNA. A PolyATract mRNA Isolation System for small scale mRNA isolation was
used for this purpose. The basic protocol involved annealing polyA+ RNA to a
biotinylated·oligo (dTI probe. The solution was then added to streptavidin coupled
paramagnetic particles (SA·PMPs). The probe bound the particles, and the particles were
captured using a magnetic stand. All unbound RNA was washed away. then polyA+
RNA was eluted with water.
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2.7.1 Materials
The mRNA isolation kit. PolyATract mRNA Isolation System ill was purchased
from Promega. ReagenlS were supplied with the kit. including; 20XSSC (Sodium
Chloride. Sodium Citrate. see 2.1.2 for concentrations), Biotinylaacd-Oligo (dT) Probe.
Streptavin-Paramagnetic Particles. Magnetic stand. and nudease free water. 1be
lyophilizer is a Jouan model from Canberra Packard Inc. and the spectrophotometer is
from Beckman.
2.7.2 Methods
Total RNA was isolated from approximately 200 embryos as per p('Q(ocol above
(approximately SOO!Jg total RNA). The RNA was resuspended in 5OOIJ.I of DEPC·trcated
water. The RNA was heat denatured at 6s<'C for 10 minutes. 3JJ,J of Biolinylatcd-Oligo
(dT) Probe and 13J!J 20X sse buffer were added and the mixture was allowed 00 cool to
room tempcrarure. The SA·PMPs were prqwed by washing with O..sX sse as per
protocol. The annealing reaction was added to the particles and the biotin-streptavidin
binding was allowed to take place over 10 minutes. 1be unbound RNA was washed off
with 4 washes of a.3m! 0.1 X sse and each time the particles were capwred with the
magnetic stand. The mRNA was then eluted with a.25ml of nuclease free water. A
spectrophotometric reading was laken for each elution step. as well as for me mRNA (0
ensure efficient isolation. The mRNA (approximately 10000g) was frozen al-7CfC.
The samples were then lyophilized 10 concentrate the RNA to appropriate volumes
for loading on Northern gels (l~). The frozen samples (in lo5m1 microfuge lUbes) were
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quickly loaded into a pre-cooled lyophilizer. The samples were allowed to spin under
vacuum for 2.5 hours. The RNA pellets were then resuspended in H)p.! of DEPC trc:a1ed
water and stored at·7(fC until needed.
2.8 Agarose Gel Electrophoresis
2.8.1 Materials
Agarose was purchased from Gibco BRL. Ethidium Bromide was purchased
from BioRad. Gels were observed under ultra~violet transilluminator from Hoefer
Scientific, and photographed using a photodocumenlation system from Stratagene.
Analysis and photographs of agarose gels were obtained using Chemilmager 4000 low
light imaging system from Canberra Packard Inc.
2.8.2 Methods
All electrophoresis gels were prepared with 1% agarose (Gibco BRL). Agarose
was dissolved and the gels were ron in IX TBE buffer (l0.8g Iris base. 5.5 g boric acid.
and 4 ml 0.5M EDTA. pH 8.0 in ILdeionized water). 6.~ of IOmglrnl ethidium
bromide were added per 100m1 gel, wilen gel was ready to be poured. This was added 10
increase visibility of the nucleic acids under ultraviolet light. Nonnally, 9~ of sample
were added to each well, along with I~ of lOX loading dye. Gels were run at IOOV for
45 -90 minutes. The nucleic acid was visualised by using an ultraviolet transilluminator
and photographed using a photodocumentation system.
so
2.9 Reverse Tl'lIJISCripllon
2.9.1 Materials
For Reve~ Transcription. the Random Primer. Firsl Strand Buffer. and Murine
Maloney Leukemia Virus (MMLV) RNA polymerase were purchased from Gibeo BRL
dNTP's and RNA Guard were supplied by Pharmac:ia BiOfech. DithiotlJreitol (Om and
Trichloroacelic Acid (TeA) were purchased from Sigma and Fisher. respectively.
2.9.2 Methods
Reverse lranscription (RT) was performed on lolal RNA isolated as above. The
volume of RNA solution used for each reverse lnU'ISCription was adjwted such that each
reaction lUbe contained 200-SOOng of RNA. The RNA was diluted in DEPC-treated Walet
to a final volume of ISJd. Two mkrolilIes ofO.IJlIf~ IUndom Primer was added and the
milllun:: was healed to 7ffC 10 denature RNA. and then qukkly cooled on ice. 8JLi of First
Strand Buffer (supplied with enzyme) was added, along with 8IU dNTP (2.5mM each
nucleotide), ~ dithiothrtitol. 1~ RNA Guard and ~ Murine Moloney Leukemia Virus
RNA polymerase. The mixture was incubaled for one hour in a 3rc w:uet bath.
A tracer experiment wao; petfonned at the same time as the reverse transcription as a
measurement of efficiency of enzyme activity. 5111 of the reVl:BC transcription sample were
removed from the miltture before the incubation step and were added to O.SJ,L1 of rJ'SJ-dcrP.
The mixture was allowed to incubate for 1hour at 3'tC and then cooled on ice. Next S<XM
of 4°C. 10% trichloroacetic acid was added [0 precipitate [be DNA and lhe mixture was
allowed to sit on ice for 10 minutes. The precipitate was then filtCTed with a glass filter and
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rinsed with more 10% uichloroacetic acid solution. The filter. along with the DNA was
placed in a scintillation vial. scintillation fluid was added and the radioactivity was counted
on a Beckman liquid scintillation system.
2.10 Polymerase Chain Reaction (PeR)
2.10.1 Materials
The following reagents for PeR were purchased from Promega; Taq DNA
Polymerase Enzyme and Buffer. and Magnesium Chloride. PeR Primers (see Table 2.2)
and dNTP's were supplied from Gibco BRL. Mineral oil was purchased from Fisher. A
Perkin Elmer Thermal Cycler was used 10 amplify DNA. Kodak X-OMAT AR film was
purchased from lnlerSdence.
2.10.2 Methods
A master mix was prepared by adding water to Taq buffer (see Table 2.4 for
concentrations and volumes). dNTP's and MgCh were added and the coments voltexed. In
most cases. more than one set of primers was used at a time. In such cases the Taq enzyme
was added next. the mixture vottexed. and a proportional volume aliquoted inlo a O.5m1
microcentrifuge lube for each set of primers, depending on the number of primers needed
for PeR. The panicular primer volume was added in proportion 10 the volume of original
master mix in the microcentrifuge tube. 24,L1 of the respective primer master mix was added
10 O.5ml microcentrifuge tubes. IJLI of the reverse transcription sample containing the first
"
strand DNA was pipctted in and then vortexed. 2Sj,d of mineral oil was added to minimize
product loss due to evaporation.
The PCR program used was as follows:
I cycle: denaturation 94"<: for 4 min
36 cycles: annealing SO"<: for 30 sec
elongation 720C for 30 sec
denaturation 940C for 30 sec
I cycle: polishing step 5(fC for 30 sec
72°C for 10 min.
Histone control reactions had 25 cycling steps. TIle sample was then brought to room
temperature. PeR products were run on a 1% agarose gel. Remaining product was stored in
Table 2.4 Reagent Volumes and Concentrations in 1001\1.1 PeR
Volume for 1000 uL Total FiIlll1 CODCODtralioD
10000IOx TAQ Buffer Img/ml
6TIIlI Deionized Water
-
8o.J 10 mM dNTP 0.8mM
60IU 25 mM MgCl, 1.5mM
20).11 100 nglul Primer *' 2ng/ILI
201011 100 nglj,d Primer 1#2 2ng/1'1
3.1 TAQ Enzyme (5"'1'1) 1.5 Ulng
40~ Reverse Transcription
"
PCR were also run using radioactive [a}2PJ ciAlll' in the dNTP in the master mix.
The only differences from those previously described arc the addition of radiolabeled ciATP
and the number of thermocytles in the PCR. which were: 19 cycles if the histone primer
was used. and 26 cycles with the other primers.
PCR prodUet5 from [a)!P] dQl) labeled PCR were run on 6%
acrylamidelbisacrylamide gel as described in section 2.3.2. The gel was exposed X-ray film
for a period of 1-3 days inside a cassette with an intensifying screen.
2.ll peR Product Quantilation
The relative levels of PeR products for each sample were analyzed differently
depending on whether radioactivity was used in the reactions. Non-radioactive samples
were run on an agarose gel containing ethidium bromide. A photograph of these gels was
taken and stored on the ChemiImager 4())) computerized system. which was also used to
perfonn image analysis. Radioactive samples I'lIn on a polyacrylamide gel were exposed to
film as described above and the film was analyzed wing the Chemilmager 4000 software.
Radioactive samples were occasionally packed with a phosphoimaging screen (multipurpose
or super sensitive) and then analyzed using the Optiquant acquisition and analysis software.
2.U Northern Blotting
2.12.1 Materials
The agarose used for RNA gels was "Ultrapure" from BRL Labs. Fisher
supplied other reagents needed. including; MOPS (Morpholinopropanesulfonic acid),
sodium acetate trihydralc. fonnaldehyde (37% w/v). and fonnamide. SOS was from Sigma
chemicals. Xylene Cyanol purchased from BioRad. and Bromophenol Blue dye from
Ele(;tran, DOH Chemicals.
Gene Screen hybridiz.alion membrane was purchased from NEN Research Products.
Dupont. Whatman paper was from Whaunan Inlemalional. sse and SSPE buffer conlcnlS,
sodium cltr:l.IC, and sodium dihydrogen orthophosphate were from Fisher and BDH
chemicals. respectively (other chemicals already given). Ultraviolet cross-linker used was
UV Stratalinker from Stratcgene. Melhylene blue stain was from Fisher Scientific.
Restriction enzymes for probe preparation wert purchased fonn Gibeo. ORL
(buffers supplied with enzyme. Ultraf~-MC Centrifugal Filter Units were obtained from
Millipore Corp.
Random Primer DNA Labeling kit was purchased from Gibco BRL Sephadex
G-SO was purchased from Phannacia. The scintillation counter used was Bec:bnan LS
3801. and scintillation fluid was from Amersham Life Sciences.
Salmon sperm DNA and ficoll for hybridization buffer were obtained from
Phannacia Biotech. Polyvinyl-pyrolidone was oblained from 80H Chemicals.
Multipurpose and supersensitive phosphoimaging screens were purchased from
Canberra· Packard. The images were scanned from the screens using the Cyclone
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Storage Phosphor System and analysed using the Opliquant image analysis software also
from Canberra-Packard Canada Ltd.
2.12.2 Methods of Northern BIolting
2.12.2.1 Running a Denaturing RNA Gel
An RNA grade gel was prepared with formaldehyde as a denaturant in the following
manner. An agarose gel chamber. tray and comb were thoroughly cleaned as to eliminate
any RNAses. 1.4g of RNA grade agarosc: was added to 84.8m1 ofDEPC-treated water and
was heated in a microwave 10 dissolve agarosc:. After cooling 10 approximately 6S"C. 12m!
of lOX MOPS buffer (O.4M Morpholinopropanesulfonic acid. O.lM Sodium Acetate
Trihydrate. O.OIM Disodium EDTA dihydrate. pH 7.4) and 23.2m1 of 37% formaldehyde
were added to gel, it was poured inlo casting tray and allowed to solidify for 30 minules.
RNA to be loaded onto gel was previously equilibrated to approximately ~gf}tl in
DEPC-treated water.
For each sample. the following were added:
I~I RNA
4.~1 5XMOPS
7.8~1 Formaldehyde
22.21L1 Deionized Fonnamide
An RNA marker was used to estimate RNA sizes. and was treated the same as experimental
RNA except only 41 of marker was loaded onlo gel with volume made up with DEPC
treated water. 11le RNA was denatured by heatinl 10 7rte for to minutes and quick-
cooling on ice. The samples were centrifuged briefly 10 settle out condensation. 4.4J1,1 of
lOX loading buffer (0.5%505. O.2S%Glycerol. O.02SM EDTA. Bromophenol Blue and
Xylene Cyanol dyes) was mixed with RNA samples
The buffer chamber was filled with IX MOPS. !he samples were loaded onto gel.
and il was run al 80V for 2.5·3 hours. or until the bromophenol blue dye fronl had migrated
IOcm. Periodically during running the gel. !he buffer was mixed between separate sides of
the chamber to prevent accumulation of ions allhe elcclrodes.
2.12.2.2 Blotting
Gene Screen membrane was hydrated wi!h distilled water. and then equilibraled in
6X SSPE buffer (for 20X buffer. 3M Sodium Chloride. 5M Sodium Dihydrogen Phosphale
Dihydrate. and O.020M EDTA. pH 7.4). The blotting tray was filled with 6X 55PE and
covered wi!h saturated no.! Whatman paper. The gel was rinsed with DEPC treated water.
invened. and placed on Whatman paper. Membrane was placed on gel (cut to size of gel).
air bubbles were removed and the membrane was cov~ with three pieces of 6X SSPE
saturated Whatman paper and paper towels. The gel was allowed to biOI overnight After
16-18 hours, the bioI was disassembled and rinsed briefly with 6XSSPE. The RNA was UV
cross-linked to the membrane and !hen dried under vacuum a180°C for 2 hours.
The marker lane portion of the membrane was cut from !he remainder. and stained
with methylene blue 10 examine the integrity of the RNA. 'The bioI was stored in a
hybridization bag.
"
2.U.2.3 Isolation 01 DNA Probe
DNA to be used for probing Nonhem blots were created from specific fragments
which had previously been insetted into pCR2.0. (or another plasmid as specified),
amplified by plasmid Jlfq) and sequenced as described in section 2.2.1. HiSlone was used as
a ronlI'Ol. These DNA fragments for probing were typically 4()O.6(D)p in size. and were
removed from the plasmid by restriction enzyme digestion. and agarose gel electrophoresis.
The digestion was conducted with restriction enzymes. which cut only at the
multiple doning site in the plasmid. Typically, EcoRV ora miJ;ture of Apal and Kpnl was
used. For the ApallKpnt digestion. I~g of plasmid DNA was incubaltd with IX React 4
buffer and 2111 (IOU/III) of Apal at 3O"C for I hour. Then 4J (IOU/Il!) of Kpnl was added
and the reaction was incubaled at JfC for 1 hour. For the EooRV digestion. IX React 2
buffer was used. along with 4d of lOU/pl enzyme at 37"C for 2 hours. The reaction was
diluled from SO to 200Jd and ~traeU:d twice with an equal volume of phenol:chJorofonn:
isoamylalcohol (25:24: 1) and pm:ipitatcd with ethanol. The DNA was resuspended in 2~
of water. 2",1 of lOX loading buffer was added and 11",1 of sample was NO in 2 wells of a
1% agarose gel. After the gel was run at IOOV for 45 minutes. the: gel was observed with a
hand-held UV source:. The band of correct Slze was cut from gel. gel was maceratt.d, and
centrifuged through a filter unit at 8<XXkpm for 5 minutes which aUow passage of the DNA
through the membrane. while retaining the: agarose within the upper chamber of the filter.
The DNA frogment was pbenol:chlorofonn:isoamylalcohol extracted and ethanol
precipitated as above. l~ was re-run on an aprosc gel 10 estinwe. conc:enttation and
remainder stOTed at -2f1'C until needed.
"
2.12.2.4 Labeling DNA Probe
The labeling rcactioo was oonducted using the Random Primers DNA Labeling
System (GibcoBRL). The DNA fragment was digested and isolated from plasmid DNA as
pt:r protocol. 5O-7Sng DNA was added [0 distilled water 10 a final volume of 2<\lI. The
DNA was denarured by boiling for 5 minutes and quick-.eooling on ice. Radioactivity was
obtained as either (~lpl-dATP or (al1pl-<k:TP, used interchangeably, substituted for me
corresponding nonradioactive nucleotide. The following components (supplied with kit,
except [cC1pl-dATP and [al1p]-dcrP) were added on ice:
2111 O.SmM dATP solution
2111 O.5mM dGTP solution
2j.l1 O.SmM dTfP solution
15111 Random Primers Buffer Mixture
4p.l dislilledwater
5.1 [a"Pj-dCTP. 3000C~mmol. 100C~oJ
ComponenlS were mixed with pipetting and centrifuged briefly. Added lid KJenow
Fragment. mixed wilh pipea.ing. and incubated 1·1.5 hours at room temperatUre.
labeled probe was isolated from unincorporated nudc:otides using a Sephadex G·50
spin column. Column was made fresh using a ImI syringe plugged at bottom with glass
wool and filled wilh Sepbadex G-SO pre-swollen in Tris-EDTA buffer. Column was packed
by cemrifuging in a clinical centrifuge at 4 for 2 minutes. Column was refilled until resin
volume after centrifugation was 1m!.
The labeling reaction was stopped with 5111 of stop buffer (supplied with kit) and
45j.11 distilled water was added to take volume up to 100\11. The labeling reaction was loaded
onto column and centrifuged in a clinical centrifuge for 2 minutes at setting 4. 1be column
"
was spun in a 15ml snap cap tube to catch e1utant. The eluWlt volume was measwed and
wns placed in a 1.5m! microcentrifuge tube. Incorporation of radioactivity was measured
with a scintillation counter. l.u and 4d of probe were aliquoted into scintillation vials
comaining scintillation fluid. The radioactivily was counted for 30 seconds and the reading
from 0 to 1000 was oblained. From this value. the (()(a! radioactivity (CPM) and specific
aClivity (CPMlug DNA) was calculated. The minimum activily used for probing blots was
IXIOS CPMlug DNA. but generally 2 X 109 CPMIug DNA was obtained. The probe was
stored at 4°C while blot was prehybridizing.
2.12.2.5 Prehybridiza_ ..... Hybridizatioa
For the first hybridization, each membrane was moistened with 2X sse (sodium
chloride and sodium citrate) buffer (see Table 2.5). Dna: blots were probed. they were
stripped and slored at 4°C in 2XSSC buffer. Once the required image was received from the
blot. the old probe was removed so that the membrane could be probed again. with a
different probe. rn the procedure of stripping the blot, the bond betw1:en the: RNA on the
membrane and the DNA probe was broken and the probe washed away. The bonds wert
broken by adding it 10 a boiling solution of0.5% SDS. and boiling for 10 minutes. The ba1h
was then removed from heat and allowed 10 cool for 10 minutes. The blot was !hen washed
and slored in 2XSSC until ready to probe.
Prior to probing the membrane, a prehybridization step was conducted. The purpose
of this step was to allow DNA (from salmon sperm) to anneal to all portions of the
membrane that did nol contain RNA, thereby preventing nonspec:iflC binding of the: probe to
the membrane. Prehybridization also sets favourable conditions for hybridization..
The volume of hybridiz.ar.ion solution needed was calculaced according to the size of
the membrane. 5OI.JIcm! was needed fcreach step (prehybridization and hybridization). The
solution was made (see Table 2.5) and placed in a 42°C water bath. The salmon spenn was
sheared by sonication. boiled 5 min (0 denature, quick-«lOled and then added 10 the
solulion. For prehybridization, the solution was added to the membrane, sealed in a
hybridization bag, and incuba1ed at 4~C with Iighl shaking for 24 hours.
To prepare for hybridization, the amounl of probe to be added to the biOI was
calculated. Typically 2Sng of DNA was added with mallimum of 5X Io'cpmlml
hybridization solution. The probe was boiled for 5 minutes to denature. and quick cooled on
ice. Iml of 42°C hybridization buffer was added to a 105m! tube and the remainder was
added to bioI (prehybridization buffer removed). The appropriate volume of probe was
added (0 the 1m! hybridization buffer. mixed, and pipetted onto bloc. Air bubbles were
removed. and the bag was heat·seaIed. Hybridization OCQ1ned over nighl in the 420C walCr
bath with light shaking.
"
Table 2.5 Composition of Hybridization Solution
Volume Added (for 10 mJ Reaamt Rea..t Composition
Solution)
5ml Deionized Formamide
2.5ml 20XSSC Sodium Chloride
SodiumCitrale
O.20ml 50X Denhardts Solution I'low/v Ficoll type 400
I%w/v polyvinyl-
pyrolidonc
1% w/v BSA fraction 5
O.2OmI 1M Tris-CI pH 7.5
I.Oml IO%SDS
I.Oml Sterile water
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2.12.2.6 WasbiDg, ExposlIlC and AaaIysis of Northern Blot
After allowing the labeled probe to hybridize to ~ching RNA sequences. the blot was
washed to remove excess and nonspecifJCally bound probe. Three wash solutions were:
made and heated to 42"<::
Wash Buffer I - 2XSSC and O.S % 50s
Wash Buffer 2 -O.SXSSC and 0.5% 50S
Wash buffer 3 -O.IXSSC and 0.1% 50S
The hybridization solution was drained from the blot and il was rinsed with wash
buffer I. More wash buffer I was added to the blot. and it was washed with shaking for 10-
15 minutes. The tempera[U~ was increased during this washing step from 42·5SOC. Wash
buffer I was poured off and wash buffer 2 added. The blot was incubaled again for 10-15
min with shaking and the temperalUfe was allowed to reach 6SOC. Wash buffer 2 was then
~moved and the radioactivity of the blot was tested with a geiger counler. If the bkK was
still 'hQ(", it was washed I· 2 more times with wash buffer 3. This washing Rep was to a
maximum of 68"C for 20 - 30 minutes. or until the blot appeared dean (very little~
from the geiger counter).
The blot was then packed with either Hay film with intensifying~n at .7Cf'C. or
with a phosphoirnaging screen (multipurpose or supersensitive) at room temperature for
approximately 7 days. The films were developed and analyzed as in Section 2.1 L
6J
2.l3 Ribonuclease ProledIon Assay
The ribonuclease (RNAse) protection assay is another method used to examine
differential expression of specific genes in various tissues or in response (0 tissue
manipulation. The theory behind the RNAse protection assay is thai only double
stranded RNA. created by the transcript of interest binding to an antisense probe. will be
protected from degradation by RNAses. Therefore. RNA is isolated from cells and
purified. A radiolabeled antisense probe is created and allowed to bind to its
complementary RNA sequence. lhe RNA is then treated with RNAses thaI digest single
stranded RNA. The digests are then run on a sequencing gel and the relal:ive amount of
RNA in various tissues is quantitated. The protocol used for this procedure is similar 10
that described in Current Protocols in Molecular Biology (Ausubc:1 et at.. 1993).
2.13.1 Materials
The dNTPs were purchased from Pharmacia BiOlech. Radiolabeled {a·HPl
dATP and [a_12Pl rUTPwere from Mandel. tJ(174 Hinfl dephosphorylated markers and
RQI RNAse free DNAse were from Promega. RNAse TI. RNA Polymerase (SP6 or
TI). rl'ITPs. K1enow (Large Fragment of DNA Polymerase I) and lOX Klenow Buffer
were supplied from GibeD BRL. Liel. and MgCI2 supplied by Fisher Scientific. RNAse
A. Proteinase K. and transfer RNA (tRNA) were from Boeringer Mannheim and Sigma
supplied the Dithiothreitol. 50S. Piperazine-N,N'- bis[2-ethanesulfonic acid} (PIPES)
and Spermidine.
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2.13.2 Methods ol RNAse Prolection Assay
2.13.2.1 Creating an Antisense Probe
Probes wen! designed to contain a S' overhang or blunt end and were 1~3SObp in
sizto Each fragment used (or creating probes in this experiment was cloned into pCR 2.0.
containing a 17 promOltr on one end and SP6 on the adler. Therefore. endonuc!eases were
used which cut the DNA insert in such a way that when they were amplified with SP6 or 17
polymerase. the correct size probe was created.
20·3D,Jg of DNA was linearized with the appropriate restriction enzyme and
resuspended in waler to give a IJig/1l1 concentration (similar protocol to that used for
northern probe preparation. Section 2.12.2.3). The probe was radioactively labeled
according to the following proIoool.
The following reagenu were added 10 a 105m! centrifuge rube:
l}oll lOX Tr.wcription Buffer (4OOmM Tris-CJ. pH1.5. 60mM MgCI2. 20mM
Spennidine)
'Id 10mM ofrATP. rGTP and rCJ1l' mixture
a.51l1 250mM Dithiothreitol
0.50\ RNAGwn1
0.81L1 57.5JlM rlITP
4.411 JOOOCiImrnoI a·np tU1'P
IIII 19U1IllRNA PoI.ymerase (SP6orTI)
2ul 1f.lg/1l1 DNA template
The contents were milted and incubated at 37"C for 90 minutes. IIl1 of 2.5mg/mJ RQI
RNAse-free DNAse was added and the contents was incubated al 3'PC for a further ISmin.
4~1 of DEpc·treated water and Ipl of IOmgfml tRNA was added. The probe was then
"
precipitated with; S~ O.2M EDTA, pH8, 6.25~ 4M ua. and 2a\Ll. IQOli, EtOH for I hour
The probe was then centrifuged at 4°C for 30 minutes, washed with 70% EIO", air
dried and resuspended in SOJU TrisIEDTA (TE). The specific activity of the probe was
counted in a scinlillation counter. An activity of O.S·I.O X Ie:! ePM is needed for addition
(0 each experimental sample.
2.13.2.2 Hybridization and Ribonucl.... Digestion
The next step in this protocol was nybridizalion of the nldioactive RNA probe to its
complementary mRNA sequence. Total cellular RNA was isolated as per section 2.6.2.
The following reagents were added to a 15ml mkrocc:ntrifuge tube for each RNA sample:
22J.ll Hybridization mix {8.3m! Deionized Formatrtide, 0.8m! SM NaC!. 0.8m!
O.SM PIPES, pH 6.4 a.lm! 100mM EOTAl
I"I RNA Probe
2~ RNA Sample (-S",g depending on level of expression within tissue)
The reagents were mixed, and the Nbcs were heated 10 8O"C for S minutes to denature RNA.
The samples were then allowed to hybridize at SCfC for 16 hours.. Next, the single stranded
RNA was digested using the following digestion mix:
10mM Tris-CI. pH 7.S
SmMEDTA
300mMNaCI
O.lllUml IOmglml RNAse A
21J,11m121lglmlRNAseTI.
3SQ,L1 of digestion mix was added to each hybridizalion sample and incubated jOmin at.
37"C. NexL the prot:ein was digested with I~ 20% 50s and 4d of ~glm! Proteinase K
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for 10 min at 37"C and extracted with phenol. The undigested RNA was then prccipiwcd
using the same method as for the probe and resuspended in 4d of TE. 2p.I of nmning buffer
was added to each sample (formamide with xylene cyanol and bromophenol. blue dyes).
A 6% polyacrylamide gel was previously prepared and pre-heated as in section
2.3.2. The samples and molecular m.arll:m (see below) were heated to 8<tC and loaded onlO
Ihe gel which was run until bromophenol blue dye fronl had reached !he bottom of the
chamber. The gel was dried and packed wi!h X-ray film overnight. Analysis of film was
conducted using the Chemilmager system.
2.13.2.3 LabeUog Molecular Markers
Dephosphexylated DNA markers. digested wi!h Hinfl. were used to identify the size
or !he assay products. The markers were radiolabeled and men run on the polyacrylamide
gel 3dj~nt to the experimental .samples. The protocol used to label the markers is as
follows; the following reagents were added to a I.SmI microcenlrifuge tube and allowed to
incubate at room tempcrarure for 20-30 minutes::
3j11 4lX 174 Hinfl dephospborylated rrwtcrs
I~I lOX Klenow Buffer (20mM Tris-O. pH8. 7mM MgClll
I~I 3.3mM dCTP
I~l 3.3mM dGTP
I~l 3.3mM dTIP
l~l (t.l!p dATP
4J.lldH!O
l~[ KJenow (Large Fragment of DNA Polymerase I)
The enzyme was then heat-inactivated at 7f!C for 10 min. lOOp.! of dH!O was
added. along with 14J 3M NaOAc and~ 100% Ethanol. The DNA was allowed to
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precipitate 31·7r!C for I hour. The precipitate was lhen cenaifuged 314"C for 30 minutes.
supernatant was decanted, washed with 70% ethanol. dried and ~uspended in~ of
TrislEDTA. 1",,1 of maril;er was added to 50tJ of running buffer and ~I was run on the
polyacrylamide gel.
2.14 Gene Cloning from eDNA Ubnuies
The following prococol was used [0 elone larger fragments of the genes isolated from
the differential display gel (see Figure 2-1). A Stage 8 Xenopus embryo eDNA library
cloned into the Bluescript plasmid. a Stage 17 Xmopw library clone into a). gtJO vector and
a human testis library cloned into pACT2 library were used.
2.14.1 Materials
eDNA libraries were prepared previously as described in Paterno er 121.• 1997. All
PeR reagents. LB. agar and agarose were supplied as above. The primer sequences are
listed in Table 2.2. The TA Cloning ligation kit and the "One Shot.. transfonnation kit
were supplied from Invitrogen. Kanamycin was purchased from Boeringer Mannhcim.
..
PCIlLilnly
~
LipIe Plodact.,pCll1
~
n.mmc...-CclllwilbpCll1
~
8pn:Id~0IILB-IIII1'IIIII
~
PCIlmTat irOmc:tP!lllid"
~
Siat·~PoiIi1I: CoIODicIc.lBKmPlllll
~
I'erlixm Pl8Did~
~
Sequeace PIumid iDIert
Figure 2.1 Strategy for Cloning from eDNA Libraries
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2.14.2 Methods oCGene Cloning
2.14.2.1 Polymerase Chain Reaction on Libraries
The S' 103' orientation of the DNA fragments was unknown, there(~ the library
was teSted in both orientations. PCR was conducted on the library with one inlemal primer
:1Jld one external (vector) primer (see Table 2.2 for sequences). The following voctor primer
sees (5' and )') were used foreac:h library;
Bluescript • T3 and n
).. GTIO- 8858 and 8861
pACI'2 - pAet'2-for and pACT2·rev.
For example, when cloning Sample 16. the ChemR-J primer was tesled with both 3'
and S' primers for each library plasmid. Serial dilutions were made for each library. PCR
was conducted for each dilution. For the genes tested. approximately I X 10' 10 I X 10'
plaque forming units (PA..ty v.l DNA was optimum. Reactions were duplicaled for each
dilution using only the 3' and 5' inlemal primers to ensure that the correct product was being
amplified. A master mix was made as per section 2.102. and the PCR program was the
same. except 33·36 cycles were used.
PCR products (ICNJ) were nut on a 1% agarose gel. Samples positive for internal
sequence. as well as yielding a larger fragment from the library, were ligated into a plasmid.
2.14.2.2 LigatioD
The next step in this prorocol was to ligare PeR product into a new vector for
amplification. The Invitrogen eDNA dolling kit with the pCR 2.1 vector was used The
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protocol is as per kit instnx:tions, and all reagents were supplied. 3: I ratio between the
estimated PeR product and vector was calculated. The following were added 10 a O.Sml
microcc:ntrifuge tube to I~ lotaI:
l·~l PCR product
1}lI Ugation Buffer
2}l1 pCR2.lvector
4-5}11 Sterile water
1111 DNAlig3Se
1be reaction was stored at 14°C for 16-.18 hours. Next the plasmids were transformed into
bacterial cells.
2.14.2.3 Transfonnation
The plasmid. conlaining the new cDNA fragment was then transformed into
bacterial cells using a lransfonnation kit. All reagents were supplied with kit. A water
bath was set to 42°C and the SOC media was thawed from -700c 10 room temperaltJre. The
competent "one shoe cells and 0.5M Ji-mercaptoethanol were thawed gently on ice. 2+&J of
p-mercaptoethanol and then 2p.I of ligation reaction were added to the competent cells and
reOlClion was allowed 10 continue on tee for 30 minutes. 1be cells were then heat shock.ed
for 30 seconds at 42"C and placed on tee for 2 minuteS. 2S(\LI of SOC media was added 10
the cells and they were grown at 37"C with shaking for 1hour.
Two aliquolS; 5C¥1 and 2lX\J.1 of the Ir.Insformed cells were spread-plaled on LB·agar
plates containing 1CX\tglml k.anamycin and allowed 10 incubate at 3'PC 16-18 hours.
Bacterial colonies were tested for plasmid insert by PCR with plasmid primer (pCR-5P or
pCR-SP) and internal primers (for sample 14.0lemR-1 and 0emR-2). Theprolocol was as
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per section 2.10.2. however. instead of adding I~ of DNA to each reaction. die co&ony was
touched with a sterile pipette tip and switted in the reaction rube. Again. both orientations
were tested. Bacterial colonies that tested positive for correct insert were streaked on an LB-
agar plate containing kanamycin and grown 16-18 hours at 37"C. A plasmid preparation was
conducted on the colonies as per Sectioo 2.2.2 and the plasmid insen was sequenced as per
Section 2.3.
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Chapter 3
Results
3.1 Differential Display
FGF elicits its cellular response by triggering a signal transduction cascade.
resulting in differential expression of target genes. The purpose of the differential display
(Liang and Pardee, 1992) conducted in this laboratory was 10 isolate eDNA fragments
represeming genes activated or repressed by FGE
The PeR-based differential display was performed by Yu Li (Paterno er ai.,
1997). A basic overview of lIle procedure is as follows. Animal cap explants were CUI
from Xenopus laevis embryos at blasrula stage (stage 8). Five different experimental scts.
each composed of 40 animal cap explants. were used in this experiment. Half of the
cxplants in each set wen: treated with lOOnglml XFGF·2 for 30 minutes. and the other
half were treated with conlrol media for the same length oftime. This was thought to be
the optimum time frame to observe differences in expression patterns of immediate-early
genes.
RNA was isolated from both sets of explants. and reverse transcription was
conducted using a T(ll)AC primer to transcribe polyA+ RNA only. The CA dinucleotide
was made to anchor the primer at the S' end of tile poly A+ tail. which binds the poly T
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region of the primer. A poly T primer without an anchor could prime anywhere along the
poly At tail and result in cDNA spectes of multiple sizes. and thus a smear on the
differential display gel (poly A+ tails may be as long as 300 nucleolides) (Liang and
Pardee, 1995).
Nexl, PeR was conducted on the cDNA using Ihe same TonAC primer and an
arbitrary random primer API or An. along with (crsS]-dATP. The amplified products
from the 5 matching sets of explant RT·PeRs were separated side by side on a
sequencing gel (FGF treated and control) and analyzed by autoradiography. Bands
appearing to be either upregulaled or downregulated in at least 4 of !he 5 sets were eluted
fromlhegel.
Six bands were isolated, all between approximately 400 and 600bp long. The
number assigned to each band, PeR primers used to amplify. relative position, and size
are given in Figure 3.1. Next, non-radioactive PCRs were conducted to further amplify
the DNA fragments isolated from !he gel. They were then ligated into pCR 2.0 plasmid
....ector and transformed into bacterial cells. From there, five cultures were grown for each
of the six bands and glyttrol stocks were made and stored at ·7O"C.
An additional differentially expressed band from !he differential display, named
early response I (trl), was cloned and characterized prior to this project (Paterno tt aI.,
1997).
The overall goal of this project was to sequence the bands amplified from the
differential display gel. examine their regulation by FGF and to determine their
expression pattern throughout XtnoplU development (figure 3.2).
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A.
600
500-
400-
B.
-
Band PCRPrimers Glycerol Stock Response to FGF
Number'S
V APZff 11 AC '-5 Downregulated
VIA AP2rr llAC 6-10 Upregulated
VIB AP2ff llAC 11-15 Upregulated
11 API fI'llAC 16-20 Upregulated
12 API ff]lAC 21-25 Upregulated
22 API/T11AC 26-30 Upregulated
Figure 3.1 Differential Display. (A) Schematic diagram of differential display gel. +
signifies the FGF treated lane, and - signifies the untreated lane. AP I and AP2 indicate
the random primers used for peR. The bands cut from the gel have been numbered
accordingly. (B) Table summarizing bands from the differential display gel.
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Figure 3.2 Flow Chart of Methodology Used to Investigate Potential Early Response
Genes.
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3.2 Sequencing and Genbank Searebes
The goal for this pan of the project was to sequence at least two of the five eDNA
fragments from each of the 6 differential display bands. The number of eDNA species in
each band was not known, however the dominant species was most likely to represent the
FGF regulated gene. Therefore. the more representative bands sequenced. the better.
However, for practicality. two bands representing the same eDNA were cloned from each
band. Cloning two bands was also useful for confirming the nucleotide sequence
between them.
I proceeded with isolating a pure colony from the glycerol siocks, perfonning a
large·scale plasmid preparation and sequencing the chosen stocks. Each gly~rol stock
was given a sample number from 1-30 for easy identification. for example, glycerol
siocks from the first band. Band V were named 1-5. (Figure 3.1).
Next. the sequence of each fragment was sent 10 the National Center for
Bioceehnology Information BLAST Network Service and analyzed using the BLASTX
1.4.1.1 program (Genbank). which compares the amino acid sequence in all six reading
frames to all other submissions. The reading frame gives reference to the position
assigned to the first nucleotide for the first amino acid in a DNA sequence. In the case of
unknown sequences, the reading frame is assigned according to the nucleic acid
sequence. For a reading frame numbering example, see Figure 3.3.
The Genbank search was to detennine whether the DNA fragment from the
potential FGF response iCne was pan of a novel gene, a homologue of a previously
n
.Z·I11~~~
l-ACGTAGGTGCGTAGTTAACTCGTACGTAC-28
TGCATCCACGCATCAATTGAGCATGCATG
tt t01~
Figure 3.3 Schematic Diagram Referencing the Six Reading Frames. The positive reading
frames reference the top sequence reading S' 103', and the negative reading frames
represent the bottom sequence reading 3' to 5' (left to right),
cloned gene from another species, or a known Xenopus gene. The Genbank identifies
regions of similar genes by the perccm identity and percent positive matches between
corresponding amino acids. Percent amino acid identity is calculated from the number of
identical amino acids, and positives include identical amino acids and conservative
changes in amino acid sequence between the two genes. For example. a change from
isoleucine and valine (two hydrophobic amino acids) would be considered a conservative
change.
A variable number of matches were obtained for each sequence sent to the
Genbank. I have selected Genbank sequences that revealed the largest number of
consecutive matches (similar or identical) to the new sequences, or mat have functional
regions mat match with the new sequences. Any amino acid domains similar to a known
gene might suggest a possible function of the gene and methods of further investigation.
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The combination of numbers and letters following the name of each gene obtained
from the Genbank is the accession number and is used to identify genes for databank
searches. The Genbank search results for each sequence arc given in the following
sections.
3.2.1 Sequencing Band V
For Band V, the only band that appeared to be downregulated by FGF treatment. I
sequenced stock numbers (Samples) I and 3. The nucleotide sequences of the 499bp
(Sample 1) and 498bp (Sample 3) vector insens arc shown in Figure 3.4. The sequences
are the same with the exception of 7 bp changes, and one ex.tra base pair inse" in Sample
I, which may have been due to PCR or sequencing errors.
A Genbank search with Samples 1 and 3 revealed similarity to the small regions
of several proteins including:
Alternatively spliced region of the transcription factor Human Myocyte- Specific
Enhancer Factor 2 (aMEF 2) (X68S03).
T-cell receptor (TCR) gamma chain V-J-C region (clone 197G I) from Ovis aries
(Z12964),
H. sapiens Meprin A Beta-Subunit Precursor (Endopeptidase-2) (X81333).
80S taurus Myosin I heavy chain-like protein (MUlC) (102819). and
Bovine hypothetical Illc.Da protein (BHP) upstream of parathyroid honnone gene
(X12515).
The regions of similarity between the unknown sequence and the Genbank
matches are shown in Figure 3.5. The significance of the search results will be discussed
in Chapter 4.
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l-CTGCTCTCAG ATGCAATGAC AACACTATCT CTATTCCAGG ATGACTTAAA
....... C.
51-GTCAAATGTT GATGTTGTTT AGTTGCTAAG TTATGTCTGA CTCTTTTGCA
lOl-ACCCCATGGA CTATAGCCCA CCTCTGTCCA TAGGATTTCC CAGGCAAGAA
151-TACTGGATGG TTTGCCACTT CTCTAGGAAA TCTTTCCAAC CCAGGGACTG
.T.
201-AACCCACATC TTGTGCTTGG CAACCGATTC TTTACCACTG AGCCACTAGG
251-GAAGCCCTTA AAGTCATATA AAGTAATGTT AATTTCAGAA TGCTTTCATA
301-TCGAAGTTAA GAGCCCAGAT AAATTTTAAA TAGCAGTGAA TCCATTGCAG
.. A. .G .. T.
351-CTATTCCCAC CAAGAGTTGG AGTCTATTTT CAACAC'l'CTC CCCTTGACTC
401-TGGGC'I'GAAT CTATGGTTTT CTTTGGCCAA CAGACTGTGC TACTTCAATA
.•... AC.
451-CTTACCTTCT TACCAGACAC TTCTATCTTG TGAAGGAGCC TGAGAGCAG
Figure 3.4 Nucleotide Sequence of Sample I (top row) and Sample 3 (bonom row). Only
the nucleotide changes are shown for Sample 3; 3. dot represents an identical nucleotide
and 3. dash represents a deletion. The number [0 the left of each line indiClUes the
nucleotide number.
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A. Human Myocyte· Specific Enhancer Factor 2
53 326-r.NGCES-H3 360-PRVGVYFQHSPLT-398
LNGCES P YF+HSPL+
&lID' 7-LoNGCES-12 l)-PDADDYFEHSPLS-2S
13119 amino acids 68~
15119 amino acids 79%
+2.+3
B. T-cell receptor gamma chain V-J-C region
51 9S FATPWTlAHLCP 130 81 121 PLSIGFPROEYW 156
FATPWT..A P PL + F RQ£YW
2 F 'rCa PLPMEFSRQEYW 24
16124 66~
18124 75%
+ .+1
C. Human Meprin A beta-subunit precursor
53 1B7·PGTEPTSV-211 83 Jl9-ESIMIPTKSWSLF-360
GTEPT V E I IPT SW L+
MAP 21B-NGTE IIU 37S-EElKEIPTGSWQLY-38B
11118 amino acids 61%
14118 amino acids n%
.2
D. Myosin I heavy chain-like protein
51 268-YDFKGFPSGSVVKNRL-221 81 llS-YSPWGCKRVRHNLATKQ 6S
+DFKGFP G V+ N L + W CK+ R L+ KQ
K~BC 167-FO L-182 Ia.c 824-FHQWKCKKFRDQLSPKQ 840
17I3Jaminoacids 51%
22/33 amino acids 66~
-3
Ii:. Bovine hypothetical llkDa Protein upstream of Parathyroid Hormone
8) 92-SFATPWTIA-1l8 83 120-TSVHRlSQARILD-158
+ TPWT+A +SVH +ARIL+
1I1D'43-Tt,vTPWTVA-51 au 54-SSVHGFFRARILE-66
83 lS4-WMVCHFSRRSFQPRD·THILCLA-222
W+ FS .. S Q R.. T .. C+A
lA-89
41%
,...
Figure 3.5 Amino acid similarities between Genbank matches and Sample 3 (and I). A.
Myocyte Specific Enhancer factor 2 (aMEF 2), B. T-cell receptor gamma chain V-J-e
region (feR), C. Human Meprin A bela-subunit precursor (MAP), D. Myosin I heavy
chain-like protein (Mmq. and K Bovine hypothetical Protein (BRP). The numbers to
the left and right of each amino acid sequence reveals the corresponding nucleic acid
number for 53 and the amino acid number for each known gene from the Genbank.
"
3.2.2 Sequencing Bands VIA and VIB
The second and third Bands (VIA and Vm) isolated from the differential display
gel represented the same Band cut from different experimental sets (Figure 3.\), therefore
one would expect that the DNA sequences would be the same. Both Bands were
upregulatcd by FGF treatment in the original differential display.
Two clones were sequenced from Band vm, Samples 14 and 15. They contained
the same 449bp sequence, with only I base pair substitution (Figure 3.6). The S' end of
Samples 6 and 7 from Band VIA were sequenced. Sample 6 and 7 showed identity to the
3' and S' end of Sample 14, respectively. Since Samples 6 and 7 appeared to represent
the same sequence as Samples 14 and 15, I focussed my analysis on the latter.
Upon sending lhe sequence to the Genbank for analysis. Samples 14 and 15
demonstrated similarity to a mouse serine proteinase inhibitor 2.4 (Spi2.4) (clone 3E46)
(X69832) and, a mouse contrapsin·related protein MC-7 precursor (XSSI48), (Figure
3.7). The serine proteinase inhibitor and contrapsin· related precursor possess the same
sequence within lhe region of similarity to Sample 14, which is partially within the
reactive centre of the enzyme. These results, as for all Genbank results. will be discussed
in Chapler 4.
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l-CTGCTCTCAG AAAAATGCTA TAGAGACGTA TATGACATAA ATAATCTGTG
Sl-ATGAAACA.~T TTAGGTTTCA TTAGCTTTTA CAAAAATGGA AAAAGTATGA
lOl-CCATGGTTGC ACAGTTTGGC AAACCATTTT TTCTATCATT CCTACAAAAT
151-ACTACTGAGT GTTACTGGAC ACTGATATGA TTATTAAAGA TATTTTCTTT
201-ATATAAATTG TATATCAATA AATTATAAAT ATGCAAGAGG TAGGTTGCAG
2S1-TTACCTACTT ACAGAAGCAA TTATCACTAA ACTGCTGACA TGCCAGTTTG
301-GTTGTTCAGC ATACT'I'CAGT ACAAACAAGA AGCTTCTGGA GTTTCCAGTA
351-CACTGCATTT TATACAAATG TAACGTATAG GCTCATAMC CTAAAGCACA
401-CTAGTTATTT AGATTTACTA CATACATAAA GATACACAGC TGAGAGCAG
Figure 3.6 Nucleotide Sequence of Sample 14. Sample 15 has the same sequence, eltcept
nucleotide 261 is G instead of A.
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Serine Proteinase Inbibitor and Contrapsin.ReJaced Pret1lrsor
814 4-KCYRDVYDIXXXXXXXXGFISFYKNGKSMTMVAQFGKPFF-99
K DV + GFI +++ + 'I'M QF +PF
BPI 4-KAVLDVAETGTEAAAATGFIFGFR5RRLQTMTVQFNRPFL-43
814 lOO-LVVQHTSVQTR5F-139
+V+ HT VQT F
BPI 44-MVISHRGVQTTLF-56
Figure 3.7 Amino acid similaricies between Serine Proteinase Inhibicor (Spn and
Contrapsin-Related Precursor and Sample 14 (and IS). The common amino acids are
printed between the two sequences, whereas conservative amino acid differences are
denoted as '+'. The values co the left and right of Sample 14 sequence are nucleotide
number, however the numbers given for SPI represent the amino acid number.
3.2.3 Sequencing Bands 11 aDd 12
Bands II and 12 were also cut from the same migration position in different
experimental sets on the differential display gel (Figure 3.1). Three clones wert:
sequenced from Band II, Samples 16. 11 and 18. Samples 16 and 18 yielded a 21lbp
fragment with only J base pair differences (Figure 3.8). Upon searching the Genbank.
the Samples 16 and 18 yielded regions of similarity to the following proteins (Figure
C. dtgans Chemosensory Receptor.
S. trpu Egg Spenn ReceptOf Precursor and,
H. injIrml"I.Qe Hypothetical Protein HlO867 (U32768).
The 636bp sequence of Sample 17 was noI similar to the other samples isolated
from band II (Figure 3.10). Upon searching the Genbank. there was only one gene with
comparable similarity 10 Sample 17. a hypolhetical19.7 Wa protein (open reading frame
2) from a fungus mitochondrion plasmid (X15982). The region of similarity is shown in
Figure 3.11.
Samples 22 and 24 were sequenced from Band 12. Sample 22 was found to be
identical to Sample 17. with only 2 base pair differences (Figure 3.10) and showed
similarity 10 the same genes (Figure 3.11). This was expected. as Bands II and 12
represent the same DNA fragment from different experimental sets of the same
differential display gel.
l-CTGATCCATG CCTCAAGTAA AATACAAMT ATAGAAGATG CCCAGCAGTA
. .c.. . ... .G.G.
51-ACGTTCAATG TAATGATTCA AGAGATTGTC AGAAAAAAAT ACATGTTAGA
..C.
lOl-TATGGCTCTG ATAAGGAATG GGAGTCAAGT GTGATAACAG GAATGGCACA
151-CACTTCTTAT AGTTAAGCAA GCTCTTTGCC ACTTTATATC AGCTCATTGC
.G.
201-CCATGGATCA G
Figure 3.8 Nucleotide Sequence of Sample 16 (top), Sample 18 (middle) and Sample 28
(bottom). The nucleotide changes for Samples 18 and 28 are given. The dots represent
identical nucleic acids.
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A. Hypothetical protein Hl0867
816 155-KCVPFtJ.,-135
KCVPFt.I..
18-KCVPFLI..-24
IDENTITY
IU 149-VfFLLSKLTPIPYQSHI"YVFFSG-18
" FLLS IPY + Y+F+ G
BI 320-IVFLLSTSLTIPYLFI..VNYLFYHG-343
17131amino acids
POSITIVES
Readin Frame
21131 amino acids
-3
68%
B. Egg sperm receptor precursor
816 64. - ITLNVTAGHLt.YFVFYt.RH- 8
~TLN+ ~ t.t. ..FV Y RH
B8R 909-LTLNICSAILLFFVt..YMH-921
IDENTITY
POSITIVES
Readin Frame
10119 amino acids
14119 amino acids
-2
52%
73%
C. C. eJegans Chemosensory Receptor
1e1 - YKVAKSLLNYKKCVPFLLSH" LPFLI -11 0
y ~ L'" C F .. PF ...
63 - YFICNLLFSMALCFAFFYQFL I PFFV- 8 8
91-NMYFFLTI-14 40-HLLYFVFYL-14
NMYFF+ + HLL...F FY+
181-NMYFFVLL-194 244-HLLFFGFYV-252
IDENTITY
POSITIVES
Readin Frame
17/13 amino acids
25/43 amino acids
-3
40%
58%
Figure 3.9 Amino Acid similarity between Sample 16 and genes from Genbank search.
A. Hypothetical protein HI0867 (HI), B. Egg spenn receptor precursor (ESR), C.
Chemosensory Receptor C. degallS (CHR). The numbers to the left and right of each
amino acid sequence reveals the corresponding nucleic acid number for Sample 16 and
the amino acid number for each known gene.
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l-CTGATCCATG GTTTAAGTAT AAATAATTGT TCACTTATAT CTGTTTCAAT
51-CACCTGTCAT TGTAGTTCCC AAAATCTCGC CTAAATCATA CATCTGCCCA
.. T.
lOl-ACCAACCTTC TAACAGCAAT GTTAGGGATG GATTCAAAAA GATCTTTGAG
151-GAAATTGGGT GGCAGATACG CGCTAACAAA GATGAGTGAT AGAAATACAA
..... C.
201-TGGTGATTAC TCCCAATCAG TATAATTCAA ATAGTATAAT GGGTATAACA
251-GTAATAGAGT ACATGACATG TTAGGCACTT ACTTTGCTGT GCCAAAGGTA
301-TTCCCATCAC TTTGTCTCTC AGAGACACCA ACAGATAGCT GTGGCCTAAT
351-CCCTATCTGT GTACCCTGCT TTAACCCAAA CTAATTGACA AACTCGAAAT
401-CGATGGTGCT AATTCACCAC CCCCATCTAT TGAGAGTACA TGCTCTCCAT
451-GTTATGTTAG CAATAGGATA AATCCTTATT TTCT'M'TTCC TATCTCCCTC
501-TGGACTCCCC ATGATCTCTA TTTTCCCAAT CGTCGGTTTC TTGCATCCTA
551-AGTAATATCC TCTTCAGGAT ACACTCATGC CTGCTAGAAG GATTAACAAA
601-TGAATTAGGC ATGATAACGA TTATTGCATG GATCAG
Figure 3.10 Nucleotide Sequence of Sample 22 (top) and Sample 17 (bonom). The
different nucleotides for Sample 17 are given. The dots represent identical amino acids.
The nucleic acid number is given at the left of each line.
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Hypothetical 19.1kDa Protein
S17 267-VMYSITVIPI ILFELY· LGVITIVFLSLIFVSAYLPPNFLKDLFESIPNI -11 B
V+ S+ V +1LF +Y L + +FL I + 11. NFL ++F+S1 +1
8P 2 5-VIKSVNVFELILFG1YXLSIFIPLFLIFIRLLAnULNFLFEVFKSIYSI - 74
IDENTITY
POSITIVES
READING FRAME
19/50 amino acids
30150 amino acids
-I
38%
60%
Figure 3.11 Amino acid similarity between Hypothetical 19.7kDa Protein (HP) and
Sample 17 (and 22). The numbers to the left and right of each amino acid sequence
reveals the corresponding nucleic acid number for Samples 17 and 22 and the amino acid
number for HP.
Sample 24 yielded a smaller insen than Sample 22. wbich was 190bp (Figure
3.12). The two DNA fragments did nOl share sequence similarity. A search of the
Genbank yielded two matching regions between Sample 24 and the NADH
Dehydrogenase (NDH) Subunit 2 from Mdospita georgiana (ARl616S2), (Figure 3.12).
,.
A. Nucleic Acid Sequence
l-CTGATCCATG CGTATAGCCT TGAATAATAA AGCTTTGCTC CCTCTAAATG
51-ACAAATACCA CAATCCACTA CTACCACCTA TGACTGCACT TGAACTTACA
101-AGTAACTAAG GGAACAAGAG GGGGATAAGA AAACAGAAGT ACAGAACTAT
151-CGCAATGACT GCTTTGTGAT CTTATTTCCT ACATGGATCA G
B. Amino acid similarity with NADH dehydrogenase subunit 2
S24 8-MRIALNNKALLPLNDKYHNP-67
M + +N A+LPL K H+P
NDB 21-MGLEINTLAILPLISKSHHP-40
S24 7l-LPPMTALELTS-IOJ
LPP+T L +TS
NDB 126-LPPITLLYMTS-136
IDENTITY
POSITIVES
READING fRAME
1613lamino acids
2213laminoacids
+2
52%
71%
Figure 3.12 Nucleic acid Sequence and Genbank Match for Sample 24. A. Nucleic acid
sequence of Sample 24. B. Sequence similarity between Sample 24 and an NAOH
dehydrogenase subunit 2 (NOH) from a Genbank search. The numbers to the left and
right of each amino acid sequence reveals the corresponding nucleic acid number for
Sample 24 and the amino acid number for NOH.
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3.2.4 Sequencing Band 22
Three clones were sequenced from Band 22. Samples 28, 29 and 30. Sample 28
was a 211bp nucleotide (Figure3.8). whose sequence was identical to Sample 16 with the
exception of 5bp substitutions. The genebank. search results were the same as for
Samples 16 and 18 (Figure 3.9). One would not expect Sample 24 to be the same as
Sample 16 because they were cut from different sized bands in the differemial display
gel. This will be discussed in the next section.
Samples 29 and 30 possessed the same 517bp sequence (Figure 3.13). with only
minor differences (8 base pair changes). The initial Genbank. search revealed that Sample
30 possessed 84% idemity (aa) and 94% similarity to a hypothetical protein; C. elegans
Cosmid T08A11.2. Due to a high degree of conservation between this fragment and the
C. elegans gene. it was assumed that this gene plays an important role within both
organisms.
Upon a second search of the Genbank.. almost a year later. the full Xenopus lae,,;s
gene had been sequenced (Schmidt-Zachmann et al., 1998). Sample 30 yields 97%
amino acid identity to a portion of the newly cloned 146k.Da nuclear protein (NP) (Figure
3.14). There are only three amino acids between the two sequences thai are not identical
or similar. The new nuclear protein is localized within nuclear spliceosomes and is
Ihoughllo playa role in nuclear splicing (Schmidt·Zachmann er a/.. 1998).
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l-CTGATCCATG AAAAGTGTTA GTGACCAACC TTCTGGAAAT CTTCCATTCC
....T.
Sl-TGAAACCTGA TGATATTCAG TACT'M'GACA AATTATTGGT CGATGTTGAT
C. . .... C.. T.
lOl-GAATCTACAC TAAGTCCAGA AGAACAGAAA GAAAGAAAAA TAATGAAATT
151-ATTGTTAAAA ATAAAAAATG GCACACCTCC AATGAGGAAG GCTGCCTTAC
......G. . .....G.
201-GACAAATAAC TGATAAAGCT CGTGAGTTTG GAGCCGGTCC ACTATTCAAT
2S1-CAGATCCTGC CTCTGCTGAT GTCGCCAACA CTTGAAGATC AAGAAAGACA
301-CTTGCTTGTT AAAGTTATTG ATGGAATTTT GTATAAA'M'G GATGACTTGG
.. A.
3S1-TCCGCCCATA TGTACATAAG ATTCTTGTCG TTATTGAACC ACTTCTGATT
401-GATGAAGACT ATTATGCCAG AGTGGAAGGC AGAGAAATCA TATCTAATTT
4S1-AGCCAAGGCT GCTGG'M'TAG CTACAATGAT TTCAACTATG CGACCAGATG
......... A
SOl-TTGATAACAT GGATCAG
Figure 3.13 Nucleotide Sequence of Sample 29 (top) and Sample 30 (bof:tom). The
different nucleotides for Sample 30 are given. the dots represent identical nucleic acids.
The nucleic acid numbers are at the left of each line.
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30 4-SMKSVSDQPSGYLPFPKPDDTQYFDKLLVDVDESTLSPEEQKERKIMKLLL
SMKSVSDQPSG LPF KPDD QYFDKLLVDVDESTLSPEEQKERKIMKLLL
UP 455-SMKSVSDQPSGNLPFLKPDDIQYFDKLLVDVDESTLSPEEQKERKIMKLLL
30 157 - KIKDGTPPMRKAALRQITDKAREFGAGPLFNQILPLLMSPTLEDQERHLLV
KIK+GTPPMRKAALRQITDKAREFGAGPLFNQILPLLMSPTLEDQERHLLV
UP 506-KIKNGTPPMRKAALRQITDKAREFGAGPLFNQILPLLMSPTLEDQERHLLV
30 310-KVIDRILYKLDDLVRPYVHKILVVIEPLLIDEDyYARVEGREIISNLAKAA
KVIDRILYKLDDLVRPYVHKILVVIEPLLIDEDYYARVEGREIISNLAKAA
UP 557 - KVIDRILYKLDDLVRPYVHKILWIEPLLIDEDYYARVEGREIISNLAKAA
30 463-GLATMISTMRPDIDNMDQ-517
GLATMISTMRPDIDNMD+
UP 608-GLATMISTMRPDIDNMDE-626
IDENTITY
POSITIVES
READING FRAME
1661171 amino acids
168/171 amino acids
+2
97%
98%
Figure 3.14 Amino acid similarity between Sample 30 and a 146kDa Nuclear Protein
(NP). The numbers to the left and right of each amino acid sequence reveals the
corresponding nucleic acid number for Sample 30 and the amino acid number for NP.
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3.2.5 Summary of Sequenced Samples and Genbank Matdles
The following Table (3.1) is a summary of the Genbank matches for each eDNA
fragment sequenced. Sample numbers are matched together according 10 their sequence
identity. The BLASTX program used here was effective for identifying similar proteins,
but would not pick up regions of similarity with the S' or 3' untranslated regions (UTRs)
of mRNAs or identify anifacts. such as amplification from ribosomal RNA (rRNA). It is
possible that the cloned eDNA fragments represented one of lhese. Therefore. as a final
search. all sequences were sent to the National Center for Biotechnology lnfonnation
BLAST Network Service and analyzed using the BLASTN program, which searches a
nucleotide databank.
The search resulls did nOI reveal sample similarity to any rRNA sequences. One
interesting result however was that the sequence of Sample 24 is identical to the Xenopus
c·mos proto-oncogene sequence with the exception of only one substirution and one base
pair deletion (in Sample 24), indicating that they may represent the same gene or a 99%
identical region from different genes. This similarity did not show up in the prOiein
sequence search; C-MOS may not have been entered in that Genbank. The new search
did not yield any new matches for the other Samples.
The sequences of all samples representing the same band, but different in size
were compared, to ensure that one sample was not a truncated version of the other
(Samples 16 and 17 for example). This [est revealed that all of the smaller sized
fragments were not simply truncated versions of the larger fragment. Therefore.
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sequencing the four unique bands from the differential display yielded sequences for six
different cDNA fragments in tOlal. The next decision 10 be made was regarding which of
the six fragments to sWdy further.
Table 3.1 Summary of Sequenced Samples and Genbank. Matches
Band # Sample Sequence Similarity
"s
V I. 3 T-cell receptor gamma chain. Myocyte- Specific Enhancer
Factor 2. Meprin A Beta-Subunit. Myosin 1Heavy Chain-Iik.e
protein, and Bovine Hypothetical II kDa protein
VIA, 14,15 Mouse serine proteinase inhibitor and contrapsin-related
vm protein
VIA, 16.18.28 C. efegans Chemosensory Receptor, S. Trpu Egg Spenn
Vm.22 Receplor Precursor, H. influertUle Hypothetical Protein
HI0867
11,12 17.22 Hypothetica119.7kDa protein
12 24 NADH Dehydrogenase Subunit 2 from Melospiza georgiana,
and Xenopus c-mos mRNA
22 29,30 Xenopus 146kDa nuclear protein
9S
3.3 Choosing Clones ror Further Exploration
Once at least 2 of 5 samples had been cloned from each band. a decision was to be
made regarding which samples 10 investigate further. There were several criteria to be
met in order for samples to be researched further. At least two of the five samples for
each band must possess primarily the same sequence. Also. the insert must have the
appropriate primer sequences on each cnd. For example, samples amplified (by PeR)
with API and TOil AC should possess either API or T(lll AC sequence at either end.
This shows that the sequenced plasmid insen was a product of the PeR. Finally. the
insert sequences should be approximately the same size as the band cut from the
differential display geL
Samples I, 3. 14, 15, 17, 22, 29 and 30 met the above criteria. but Samples 16. 18.
24 and 28 did not. Even though Samples 16 and 18 are almost identical and possess the
correct primer sequences al both ends, they are the incorrect size. They are only 211bp,
but they represent Band II. which was approximately 600bp. Further to this, it was
discovered that Sample 28 was composed of almost the same sequence as Samples 16
and 18. However, Sample 28, which was 211bp. came from Band 22, which was
approximately 500bp. The same observation was made regarding Sample 24. Sample
24, when sequenced, was shown to be a 190bp fragment. but il was supposed 10 represent
Band 12, which was approximately 600 base pairs.
Due to lhe observations made above, and time resuictions, many of the
incorrectly sized samples were excluded from further experimentation. From the correct
96
sized sequences, one clone was arbiuarily chosen from two similar sequences (example:
Sample 3 was chosen from 1 and 3). The following DNA samples were chosen for
further research; Samples 3. 14. 17. and 30 (Table 3.1).
Table 3.2 Differential D1splay Samples to be Studied Further
BlIDd' AP...-e·BlIDdSbo .......-no SompIeSbo
(CoIoay"s) (DP) s..- (DP)
(-
-
doe ...
=.w-:":~
V 500 3 498
(1-5)
VIA and vm 450 14
449
(6-15)
II and 12 >600 17 633
(16-25)
22 >500 30 516
(26·30)
3.4 XFGF·2 Regulation of Gene Expression
Upon collecting all of the sequences, the next task was to confinn thai the genes
partially cloned in the previous sections are regulated by XFGF-2. This task proved 10 be
quile difficult. Many genes that playa specific role in development are present wilhin the
cell for a short period of time. This is contrary to what would be observed for
housekeeping genes, which are imponant with in the organism throughout its life span
and present in abundant levels.
Firstly, the experimental conditions for FGF treatmem were repeated from the
differential display protocol. Animal cap explanlS were cut from Xenopus lacYi! embryos
at Stage 8 (according to Nieuwkoop and Faber, 1967), and lrC:atcd with lOOnglml XFGF·
1 or control NAM/2 +BSA solution for 30 minutes. RNA was then cXlracted from the
explants. In order to ensure that there was a response to XFGF-2 in animal cap explants,
control animal caps were cut and left in NAM/2 solution for 2 days. They were then
scored for induction, observed morphologically under a microscope. If the control
XFGF-2 trealed explanls were induced, it was accurate to assume that the XFGF-2 was
effective on the experimentally treated explants.
Nonhern blotting was the fint of three protocols used for FGF regulation studies.
Besides giving information regarding regulation by FGF. Northern blots give infonnation
about the size of the gene being examined as well as whether there arc multiple genes
(gene family). This method is also effective in quantitating relative levels of RNA from
different tissues.
"
3.4.1 Northern BIoi Analysis
Northem blots were conducted using RNA from FGF treated and untreated
animal cap explants as described above. DNA probes were made by labeling sample
eDNA fragments with [al!Pj-dCTP. Nonhern blots are very effective for comparing
differential expression of genes, and also give the size of the complete mRNA product. as
mentioned. However it is insensitive relative 10 PeR. and is dependent upon me level of
mRNA made from the gene of interest compared 10 the 10lal RNA within the cell. of
which only 3-5% is messenger RNA.
Samples 3, 14, 17 and 30 were used to probe Northern blots. The RNA was
isolated as described. treated and untreated explants were used from the same experiment,
loading levels were nonnalized using histone 4 (H4) probe as a conlTO!. Xenopus H4 is
an important nuclear protein expressed at constant steady state levels in all cells.
I was unable to detect mRNA representing Samples 3,14, or 17, even when using
'supersensitive' phoshorimaging screens or X-ray film packed with intensifying screens
and exposing up to two weeks. This may have been due to low expression of the genes
represented.
Sample 30 was detected by this method. however (Figure 3.15). The Northern
blot contained the untreated explant RNA in lane 1 and the FGF-2 treated explant RNA
lane 2. Distinct 4.4kb bands were obtained, the same size as those in blots of the nuclear
protein cloned by Schmidt-zachman ~t al., 1997. When the values were nonnalized with
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A.
Sample 30
Histone 4
B.
Con I FOF I Con 2 FGF 2 Con 3 FOF 3
Figure 3.15 Northem Blot showing regulation of Sample 30 by XFGF-Z. Northern BIoI
was created with RNA isolated from animal cap explants. A. Top panel; Sample 30
probe. Bottom Panel; Histone 4 Probe. Lane 1; Untreated control explant RNA. Lane 2;
XFGF-2 treated explant RNA (30 min.). B. Histogram of relative expression levels of
Sample 30 from the above Northern Blot (Con 1 and FGFI) and two other Northern Blots
Con 2, 3 and FGF2, 3). Quantity of RNA used: Set 1-1311g; Sct 2-28l-l.g and Sct 3-50~g.
The values were obtained by spot densitometry using the Chemibnager System
nonnalized with histone.
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H4. it was shown that there was a 2·fold increase in the steady stale levels of Sample 30
mRNA after treatment with FOF. However. in two other Northern blots. the level of
Sample 30 was approximately equal or slightly decreased in response to FGF treatment
(Figure 3.15 (B»). Thus no conclusion could be made regarding regulation of Sample 30
gene expression by FGF.
A second type of Northern biOI was made using PolyA+ RNA from FGF treated
and untreated explants. This method is more sensitive for detecting genes that are
expressed at low levels. With only mRNA being loaded onto the gel. a much higher
amount of mRNA could be loaded into each lane. The blot was probed with Sample 17
and exposed using double intensifying screens for up to 13 days. but there was no visible
product for Sample 17 at any exposure.
Although precautions were taken to prevent RNA degradation (described in
Chapter 2). it is possible that the RNA was degraded before or after it was loaded onto
the gel. This could be a reason for the lack of signal form Sample 17. Probing the
Nonhern Blot with a control nwt.er such as Histone. woukl test the integrity of the RNA.
(0 ensure it was not degraded. However. neither control markers or other experimental
samples have been used to probe this Northern blot. this should be done in the future.
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3.4.2 Ribonuclease Protection Assay Analysis
Ribonuclease (RNAse) protection assays were atlempted next, because it is a
more sensitive method than Nonhem Blotting. As mentioned, the genes being examined
may be expressed at low levels. tllerefore they may be visualized by using RNAse
protection assays.
The principle behind RNAse protection is that of all the RNA isolated from a cell
population, only double stranded RNA. which is created by RNA annealing 10 a
radiolabeled amisense probe, will remain inlact in the presence of RNAses that degrade
single stranded RNA. This double stranded RNA is run on a polyacrylamide gel and
relative levels of product for each experimental condition is quantitated.
The protocol was initially tested using an antisense probe against a portion of
FGFR I mRNA as a control. This assay worked quile well. the same protocol was tested
using FGF treated and untreated explant RNA and an antisense probe created from
Sample 3 eDNA. The antisense direction for Sample 3 was chosen because four out of
five genes from the genebank search with high similarity match in positive reading
frames. Therefore the antisense probe was created 10 anneal to Sample 3 in the 5' 10 3'
orientation shown in Figure 3.5 (Page 81).
The RNAse protection for Sample 3 did not work. There was no specific
protected fragment observed. A control RNAse protection assay was conducted in order
to test that the RNA probe was not degraded and was able to bind its complementary
sequence under the experimental conditions. Since RNA is susceptible to degradation. it
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is possible thai the probe (or cellular mRNA) was degraded before it annealed 10 its
complementary sequence, however this was not observed in the conlrOls.
A control assay was conducted by creating both sense and antisense mRNA from
Sample 3 cDNA. The sense mRNA represented the cellular mRNA and was expected to
bind 10 the anlisense probe, and to remain intact during RNAse tteatment. The antisense
RNA was a Controllhat would not bind Sample 3, because they are the same sequence,
therefore it would be degraded.
A 209bp fragment was created from the Sample 3 probe, but since a portion of
this probe was composed of uncomplimentary vcctor RNA. degraded by RNAses, the
double stranded fragment (protected fragment) was 142bp. It was shown that the
antisense probe was able to proteci the sense mRNA (representing the cellular mRNA)
from RNAse degradation. However the antisense RNA, as expected, did not anneal 10
the antisense probe and was effectively degraded (figure 3.16).
In Ihe same experiment, Xenopus Stage 18 RNA and Xenopus adult lung RNA
were also probed with Sample 3 antisense RNA. No protected product was observed on
Ihe polyacrylamide gel.
The assay was shown to work. with the FGFR I under cellular conditions (dala not
shown) and with Sample 3 using control RNA. but did not work. with Sample 3 using
RNA from Xenopus explants, Stage 18 embryos or adult lung. This was most lik.ely due
10 the relatively low abundance of message, or may also be due to incorrect orientation of
the probe. This would mean that the probe was sense, not antisense and the cellular
mRNA was the same. not complementary to the probe. as will be discussed further in
Chapler 4. The other samples have not been tested by this method.
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1 2 3 4-
209bp ~ ...
, .... Probe
142bp ~ •..~\
~;~~~~;dlgo~os~~~~r;~~~~.t~~di~;~~1~J~~:e~~~£~~~1~e3 ~~e:fs209bP was
created to anneal to complementary RNA. Lane I, Sample 3 Sense RNA(lOOng) and
Antisense Probe. Lane 2, Antisense Sample 3 RNA(lOOng) and Antisense Probe. Lane 3,
RNAse treated Antisense Sample 3 Probe. Lane 4, Untreated Antisense Sample 3 Probe.
Upper left and right Arrowheads-209bp Probe. Lower left arrowhead- 142bp Protected
Fragment.
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3.4.3 RT-PeR ADaly'"
The most sensitive method for detection of low levels of RNA is RT-PCR
because the specific sequence is amplified ar. an exponential rate. However. this method
was usW. for the initial differential display, and it was favorable to verify the observations
regarding FGF responsiveness using a different proc:ocol. RT-PCR was chosen only after
the mRNA levels were not detected via northern blotting or RNAse pTOlection assay.
peR primers were designed for the newly cloned genes. One S' and one 3' 20-
mer primer were made for Samples 3. 14, 17 and 30 (sequences shown in Table 2.2. Page
40). The primers were shown to effectively amplify lite sample eDNA in control
experiments. therefore they were working as expected. Explants were FGF-treated and
RNA isolated as previously described. Reverse transcripc:ion and PCR were conducted
on several sets of control and FGF trealed explanlS.
The amount of eDNA added 10 each PCR reaction was nonnaJized with H4.
Equivalent levels of histone 4 represent equivalent cDNA (and input RNA)
concentrations. Therefore. differences in PCR product levels between samples represent
differences in expression. not differences in overall cDNA levels added 10 the reaction.
The PCRs were repeated several times, varying the number of cycles. to ensure
that the reaction conditions were nOI creating saturaled amounts of products, especially
for H4 and Sample 30. tf the DNA products were al saturating levels. one would be
unable to accuralely quanlilate relative expression.
Ill'
The amount of PeR product increases exponentially with every cycling. Sample
14 was not detectable even with a 38 cycle PeR program which is thought to be the
upper limit for Taq DNA polymerase activity. After this time. the enzyme loses activity,
and is no longer efficient for additional cycling. Tht: absence of Sample 14 in FGF-
treated explants indicates that either the representative gene is expressed at very low
levels or it is a product of contamination that is not actually expressed at all in Xenopus
faevisexplants.
Samples 3, 17 and 30 were visible by PeR. Regulation by FGF was determined
by using spot densitometry (Cbemilmager 4(00) to compare relative levels of PeR
products for control and FGF explants. Sample 3 was downregulated in varying amounts
by FGF treatment in all three of the experiments shown (Figure 3.17). Sample 17 was
upregulated by FGF treatment in the one experiment, but the PeR must be repeated in
order to conclude FGF regulation. Sample 30 was upregulated by FGF treatment in three
of four experiments. Thus. again the experiments did not allow confirmation of
upregulation of Sample 30 by FGF·2. These results as well as those for the Sample 30
Northern blots will be discussed further in Chapter 4. For all three samples, further
experimentation and statistical analysis must be perfonned. to confinn or rule out FGF-2
regulated expression.
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A. SampleO~.l .,- -=;;- -,
, ."+------------1,
t
~ 0,1
~
B. Sample 17
CI FI C2 F2 C3 F3
:.:(tGE1·, .mt .. i
~ 0.' !
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• I
c. Sample 30
CI FI
..-
:..:=.. . ....... ~
'.'
CI FI C2 F2 C3 F3 C4 F4
Figure 3.17 Samples 3, 17 and 30 Response to FGF: PCR Results. Xenopus Explanls
were treated with loong/mt XFGF-2 or control for 30 min., RNA was isolated and RT4
PCR was conducted according 10 the Materials and Methods section. Results were
quantitated with spot densitometry using the ChemiImager 4000 system and normalized
by calculating ratios with histone values. Control (C), explants; white, FGF (F) treated
explants; black. Numbers on X-axis indicate matching pairs for different experiments. A.
Sample 3 PCR results. B. Sample 17 PCR results. C. Sample 30 PCR results.
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3.5 Developmental Expression of Potential FGF Response Genes
Studying the expression levels of genes throughout development is often very
usefuL Since the genes being studied here are potential FGF-2 response genes. they
should be expressed when FGF is active. Since FGF-2 is a proposed mesodenn inducer
(Slack ~I ai.. 1987). one would expect that genes activated/repressed by FGF-2 are
imponant for mesodenn induction. The stages of development at which genes are
expressed indicate the time-points during which they are important. Expression of the
genes throughout Xenopus development was examined using Northern blotting and PCR.
RNA was isolaled from whole embryos at the following general developmental
stages; first cleavage. mid-cleavage. early blastula. late blastula. early gastrula. mid
gastrula. early neurula. neurula. late neurula. tailbud. late tailbud (Figure 1.1. Page 12).
The RNA was used for Northern bl<Xting and RT-PCR. Northern blotting was the first
protocol investigated due to favourable properties mentioned earlier. Since most samples
were difficult to detect in explant Northems. RT-PCR was used as an alternative test.
3.5.1 Developmental Northern Blots
Nonhern blots were made using RNA from the developmental stages listed in the
previous section. Samples 3. 14, l7 and 30 were used 10 probe blots containing RNA
from various developmental stages. Again. Sample 30 was the only one detected on a
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Northern blot, revealing a 4.4kbp band the same size as obtained by Schmidt·'Zachmann
and colleagues for the 146kDa nuclear protein (1997) (Figure 3.18).
Sample 30 is expressed throughout development. The relative levels of Sample 30
mRNA were quantitated using spot densitometry (Optiquant Analysis Program) from
three different Northern blots. The values given for each developmental stage have been
normalized by dividing by the densitometry reading for histone 4 (Figure 3.19). There
appears to be some variation in Sample 30 expression between developmental stages and
there was a general trend as follows: expression increases slightly from first cleavage to
Stage 8-9, and then decreases at gasuula Stage 10-10.5. There is an increase in
expression after gastrulation and then a decrease again at mid to late tailbud. Stages 30·
35.
The Northern blots used to this point contained approximately 201J.g total RNA
per lane. Since this method was not sensitive enough to pick up signals from Samples 3,
14 and 17, again poly A+ RNA was isolated. Approximately 7\.lg of messenger RNA
was run on a Northern gel isolated from Stage 8-8.5 and Stage 8.5·9 embryos. As a
control. 10000g of remaining RNA (primarily ribosomal RNA) which was eluted as waste
during the poly A+ RNA isolation was also loaded onto the gel. The blot was first
probed with Sample 3 (Figure 3.20). The probe has bound to the poly A+ RNA (first two
lanes) without binding to ribosomal RNA (last two lanes).
There were three detectable bands in the mRNA lanes, approximately 4.8kbp.
3.4kbp and 2.7Ic.bp. The upper and lower bands are approximately the same intensity, and
are darker than the middle band. Expression at Stage 8·8.5 is higher than at Stage 8.5-9.
I'"
Developmental Stage
5 8 1010.5 II 13 17 23 32
Sample 30
Histone 4 III
~ Northern Blot Containing RNA from Developing Xenopus embryos.
Developmental Stages are shown above top panel. 30ug RNA was loaded into each well.
Northern was probed with Sample 30 Radiolabeled DNA Fragment (top panel), and
Histone 4 Radiolabeled Probe (bottompanel). Sample 30 band was 4.4kbp.
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Figure 3.19 Sample 30 Expression in Xenopus Embryos Throughout Development.
Northern blots containing RNA from developing embryos (Stages shown on horizontal
axis) were probed with Sample 30 and then H4. Spot densitometry was conducted and
the values were divided by H4 values to nonnalizc. The nonnalized values are given. A.
Northern Blot 1 (from Figure 3.19), (30l1g RNA each lane) B. Northern Blot 2, (4011g
RNA each lane) C. Northern Blot 3 (201lg RNA each lane).
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1 :2 :3 4
4.8kbp ~
3.4kbp ~
2.7kbp ~
~ Northern Blot Containing Xenopus Stage 8 and Stage 9 mRNA. Sample 3
radiolabeled eDNA was used to probe. Lane 1, Stage 8-8.5 mRNA. Lane 2, Stage 8.5-9
mRNA. Lane 3, Stage 8-8.5 Poly A- RNA.. Lane 4, Stage 8.5-9 Poly A- RNA ..Lanes 1
and 2 contain 8ug PolyA+ RNA. Lanes 3 and 4 contain 80ug Poly A- RNA.
112
The appearance of three bands on the Nonhem blot indicates lIlal Sample 3 is a member
of a gene family. or is a single gene that can be alternatively spliced. This blot was also
probed with Sample 17 however. there was no product visible. even for exposure times
up to 13 days.
3.5.2 peR Analysis of Expression Throughout Konopus Development
PCRs were conducted using primers for Samples 3. 14, and 17. Again. H4 was
used as a control. The PCR was set up according to protocol and the optimum number of
cycles were used so that lIle products were visible when run on a gel. but nO! too high
such that the products were no longer within the linear range on the exponential curve
(saturated). Thiny·six cycles were used for all experimental sets and 27 cycles were used
for H4. The developmental stages tested in this experiment were as (ollows: 2. 5. 8. 9.
10.5, II. 13. 15. 18,25. and 33.
The results show that Sample 3 was expressed al Stages 8 and IS (Figure 3.21
(Al). Again. there was no PeR product observed for Sample 14 at any stage in
development. No product at a high number of cycles indicates thai either the gene is
expressed only due to FGF induction at very low levels during development or not at all.
Sample 17 was expressed at Stage 8 only (Figure 3.21 (B» which coincides with the
developmental stage during which mesodenn induction is known to occur. H4 was also
used as a control for relative cDNA levels in this experiment (Figure 3.21 (e».
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Stages
2 5 S 9 10 11131517 2332
Sample 3
B.
Stages
2 5 S 9 10 11131517 2332
Sample 17
C.
Stages
2 5 S 9 10 11131517 2332
~ - ......... -- Histone 4
~ Developmental peR from Xenopus Embryos. peR was conducted on RNA
extracted from embryos throughout development (Stages are listed on top of image). RNA
was isolated, reverse transcription and peR were performed according to the protocol in
Materials and Methods section. The peR products were run on a 1% agarose gel and
photographed with the Chemilmager camera.. Panel A. Sample 3 peR products; Panel B.
Sample 17 peR product; Panel C. Histone 4 Control peR products.
114
3.6 Cloning Larger eDNA Fragments
The next set of experiments in this project involved attempting to clone larger
fragments of the proposed FGF early response genes. There are many advantages to
obtaining the full gene sequence. If this were done, the full amino acid sequence could
be obtained. and various domains could be identified. thereby indicating possible protein
function. A number of useful experiments could be conducted. such as overellpression
and mutational analysis, which would again give infonnation regarding the function of
the unknown genes.
I attempted to clone larger fragments from Samples 3 and 14. Due to low
expression of the gene represented by Sample 3 and inability [0 detect Sample 14 at all.
the cloning methodology used was such thaI the experimentaJ conditions were optimized.
A Stage 8 Xenopus eDNA library was used for cloning. The stage 8 library was a logical
choice since it was lhe slage from which RNA was isolated for lhe differential display
and Sample 3 is expressed at lhis stage.
Initially, a PeR was conducted wilh lhe internal PeR primers to tesl whether the
cDNA was present in the library. Internal primers are lhe primers designed specifically
to anneal to the 5' and 3' ends of the sequence being studied. Several dilutions of the
library were tested. The initial PeR was repeated several times, each time modificalions
were made to funher optimize the conditions. For example, a 'hot stan' was conducted
whereby the Taq DNA polymerase was added after me reaction had reached 94°C in
order to prevent primer annealing to and amplifying non·specific DNA. The number of
,I>
cycles used for the PeR were also increased (see Section 2.14.2. Page 70). The specific
gene products for Sample 3 and 14 were not observed in this cDNA library. therefore it
was not productive to proceed further with cloning.
A Stage 17 neurula cDNA library was also lcsted using these cloning techniques.
Sample 3 is expressed at Stage 15. expression at Stage 11 was not tested prior to this.
Research with the neurula library did not yield any more sequence of Sample 3 or 14.
FGFR was used as a positive control for the cloning techniques. When a PeR
was conducted on the library using internal FGFR primers. one distinct band of the
correct size was obtained. thus showing that the FGFR was present in the library and
undegraded. Secondly. when cloning with the imernal and external primers. in order to
clone the full 5' or 3' piece, one distinct band was obtained that was also the expected
size. Since the control experiments worked. the problem with cloning the Samples 3 and
14 was thought to be due to low level expression. not technique.
3.7 Summary
The goal of sequencing two samples for each of the bands cut from the
differential display gel was met. and clones were chosen for funher study. The results
are summarized in Table 3.3. DNA representing band V (Samples I and 3) has shown
similarity to Myocyte- Specific Enhancer Factor 2. T-cell receptor gamma chain, Meprin
A Beta·Subunit. Myosin I Heavy Chain-like protein, and BovineHypothetical 11kDa
"6
Table 3.3 Summary of Cloning. and Expression Results for Potential FGF Response
Genes.
Band # Sample Sequence Similarity Conformation Developmental
• -FOF ElI:~ion
regulaled (Stages)
V T-cell receptor gamma chain. Yes- 8 and IS
Myocyte- Specific Enhancer Downregulaled
Factor 2. Meprin A Beta-
Subunit. Myosin I Heavy Chain-
like protein. and Bovine
Hvnothetical IlkDa Drotein
VIA, 14 Mouse serine proteinase
vm inhibitor and conuapsin- related
orocein
11.12 17 Hypothetical t9.7kDa protein Inconclusive
22 30 XenoplU 146kDa nuclear Inconclusive Throughout
protein. Development
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protein. Sample 3 is expressed in normaJ embryos at Stage 8. 9 and IS and was
downregulated by XFGF-2 as observed via RT-PeR. Results from an mRNA Northen
blot. indicate that Sample 3 may be a member of a gene family. with products of
approximately 4.8k.bp. 3.4kbp and 2.7kbp in size.
From Bands VIA and vm. Samples 14 and IS possessed amino acid similarity to
a mouse serine proteinase inhibitor Spi2.4 and a mouse contrapsin-related protein Me-7
precursor. Expression was not observed via PCR. or Northern blotting. Therefore. this
gene appears to be expressed at very low levels. if at aJl, in both animal cap explants and
in whole embryos throughout development.
Samples 17 and 22. the representative clones from Bands 11 and 12. showed
similarity to hypothetical 19.1 Jilla protein (open reading frame 2) from a fungus
mitochondrion plasmid. Of the developmental stages tested. Sample 17 is expressed only
at Stage 8. and was upregulated by XFGF-2 treatment in one RT-PeR experiment. This
is not enough to conclude that FGF controls Sample 11 gene expression.
Band 22 represents a known Xenopus 146kDa nuclear protein. It is expressed
throughout development at a fairly constant rale. but ckcreases slightly at gastnJlation and
again at mid-tailbud stage. Regulation of the Sample 30 gene by XFGF-2 could not: be
con finned via Northern blot and RT-PeR studies.
"'
Chapter 4
Discussion
4.1 FGF and Cancer
As described previously, several Igfs were originally discovered due 10 their
expression in various cancers. FGF·( to FGF-6 have all demonstrated an ability to
transform cullured fibroblasts. Aberrant cltpression of 181-2. or fgf-4 results in dramatic
changes in the genetic stability of cells. leading 10 increased drug resistance and high
rates of gene amplifICation (reviewed by Wright and Huang. 1996).
Fibroblast growth factors. including FGF·I, FGF-2 and FGF-4 play a role in
angiogenesis (Deroanne ~t aI., 1987). FGF-2 is a known angiogenesis factor in breast
cancer. for example (Wang e.t al., 1998). In order for tumors 10 grow.lhey must establish
11 blood supply. Therefore. inhibiting the actions of FGFs, which are CltptUSed at high
levels in some tumors. may restrict rumor growth by cutting off its blood supply.
It is obvious Ihal FGF is a very important molecule. In order to understand the
mechanism of action of FGF, we must first elucidate the pathways whereby it elicits its
action.
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4.2 How to Find Early Response Genes
The main inlerest of this study was to identify and characterize genes aclivated by
FOF. There are several methods used 10 distinguish differentially expressed genes.
These include subtractive hybridization (Duguid et ai.• 1988). RNA arbitrarily primer
peR (AP-PeR) fingerprinting (Welsh etal., 1992) and PeR- based differentially display
(Liang and Pardee. 1992).
The basic protocol for subtractive hybridization is based on comparison of cDNA
libraries from IWO different cell populations. The single-stranded cDNA library from
control cells is biolinylated and hybridized to the single stranded experimental library.
All double stranded hybrids and single stranded control cDNAs containing biotin are
removed. The remaining cDNAs. those that are not present in the control library
(differentially expressed). are then transfonned inlo bacterial cells (Duguid et al.• 1988).
Bacterial colonies are probed with nonnal and experimental radiolabeled cDNAs
separately (colony hybridization). The differentially expressed cDNA fragments are
isolated from the bacterial cells and sequenced (Duguid et al .• 1988). Disadvantages of
this procedure are that it is quite laborious. requires a large amount of mRNA. and is only
able to identify upregulaled genes, not downregulated.
AP-PCR fingerprinting is quite similar 10 differential display. The main
differences between the two is that AP-PCR fingerprinting stans with mRNA and only
uses one arbilrary primer (20bp) for both the reverse transcription and PeR (Ayala et ai..
1995).
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Differential display methodology is a popular method for efficiently and
effectively identifying differentially expressed genes. The procedure has been
successfully used for identification of genes differentially expressed in cancers, hem
disease, embryogenesis, and in response to growth factor stimulation. among others
(Liang and Pardee, 1995). I have chosen differential display for my study of FGF·2 early
response genes: the advantages and disadvantages of such will be discussed in the next
section.
4.2.1 Advantages and Disadvantages of Differential Display
Differential display is a means of isolating differentially expressed genes in a fast
and relatively uncomplicated procedure. The methodology also allows a potentially large
number of genes to be isolated and various experimental conditions to be tested in one
experiment.
The differential display protocol was designed to amplify messenger RNA
transcripts by using a polyT primer to make cDNA. Both the polyT primer and one of
two arbitrary primers (API or An) were used for the PeR. Interestingly, all of the
clones amplified by PeR in this experiment contained either the AP I or An primer on
both ends, none had the polyT primer and therefore did not contain the polyA+ region.
This observation was made in previous studies (Tokuyama and Takeda. 1995: Guimaraes
et al., 1995) and makes the prOlocol similar to AP·PeR fingerprinting.
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As a precaution to ensure that the clones that I have sequenced are mRNA, not
rRNA or tRNA, the nucleic acid sequences were sent to a nucleotide Genbank. None of
the clones showed any similarity to rRNA or tRNA sequences, and are therefore thought
to represent mRNA sequences.
As previously described, none of the sequences isolated in this study were
anchored at the polyA+ tail, each sequence was flanked by the internal primers.
Therefore. the cDNAs may be: from any site along the mRNA message including the 5' or
3' untranslated regions or the coding region. Anchored cDNAs would all be from the
highly variable 3' untranslated region. Internal primers are favourable for isolation of
cDNA coding regions.
Cloning a central coding region of mRNA is very helpful for identifying
functional domains in the new clones and are much more useful when searching the
Genbank. Therefore, the protocol used for this differential display was very effective in
isolating potemiallranslated regions.
Differential display has the drawback. of creating false positives however. Since
its first introduction. several modifications have been made to the differential display
protocol to reduce the number of false positives created. For example, it is important 10
ensure the RNA is free of chromosomal DNA contamination by treating with a DNAse
before reverse transcription. Otherwise, the primers may anneal to and amplify
chromosomal DNA. thereby increasing (or creating) a signal aberrantly. Liang and
Pardee themselves admit thai false positives may never be: eliminated from differential
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display and the "gold standard" for confirmation that a gene is differentially expressed is
Northern blotting (Liang and Pardee, 1995).
4.3 Problems Encountered in this Study
There were several problems encountered in this study that were either
unforeseen. or unavoidable. For example, the low level of expression of some of the
genes could not be avoided. However PeR contamination was a problem that was
avoidable to some degree. The following is a discussion of the problems encountered
:lnd how they were managed.
4.3.1 Different DNA Fragments Extracted from the Same Bands
Four distinct bands were initially cut f,om the differential display gel. When the
DNA fragments were cloned, however, there were seven distinct sequences. Band V
yielded Sample 3 (I), Bands VIA and VIB yielded Sample 14 (15), Bands II and 12
yielded Samples 16 (18 and 28), 17 (22) and 24 and Band 22 yielded Sample 30 (29)
(similar samples are given in brackets). It is not uncommon to find more than one DNA
fragment represented in a single band (reviewed by Liang and Pardee. 1995).
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I chose to examine the DNA fragments Ihat were the same size as the bands cut
from Ihe differential display gel (Samples 3.14,17 and 30). These fragments most likely
represent the differentially expressed bands.
Samples 16, 1824 and 28 were nOI thought to represent differentially expressed
sequences for the following reasons. Firstly, they were nol the correct size. Sample 16
and 18 were 211 base pairs, but Band II, which they were supposed to represent, was
approximately 600bp. Samples 24 and 28 were I90bp and 211bp, respectively. but they
represented Bands 12 and 22, which were approximately 600bp and SOObp.
The samples could nOI be: excluded solely on size. however. During the cloning
process. the eluted DNA bands were re-amplified by PCR prior to ligation into a plasmid
vector. Therefore. there could be several reasons for the samples being the incorrect size.
For example_ if there was more than one site for the PCR primers to anneal, a smaller
ponion of Ihe original DNA fragment could have been amplified during the second PeR.
Also. bacterial cells sometimes modify foreign plasmids. thereby reducing the insen size.
Therefore. upon first consideration. the samples could represent a truncated version of the
differential display bands.
If the samples were simply truncated versions of the bands, they would have the
same sequence as the cOTTectly sized samples. For example. Sample 16 would simply be
il truncated version of Sample 17. This is not the case for any of the smaller samples, as
detennined by comparing nucleic acid sequence. Also, Samples 16 and 18 represent the
same sequence as Sample 28. but they are from different bands. Therefore, it is less likely
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that Samples 16. 18. 24 and 28 represent FGF early response genes. This was not
con finned. however.
If these samples were caused by contamination. what could be the source? Since
all four samples contained either the API or An primer on both ends. the contamination
would have occurred during or prior to the reamplification PeR. If the contamination
was initiated during ligation of the fragment imo the plasmid. or within the bacterial cells.
the DNA would not possess the correct primer sequence on both ends. Therefore the
most likely source of PeR contamination would be due to contaminants from the
solutions or from the surrounding environment entering the reaction tubes.
4.3.2 Inability to Detect Gione Expression
The protocol used for differential display can allow the amplification of
transcripts of genes that are expressed at very low levels. The very nature of PeR is to
amplify DNA at an exponential rate. Therefore. when less sensitive methods. such as
Northern blouing are used for analysis. the new gene transcripts can be difficult to detect.
It is common for differential display bands not to be detected by Northern blotting. due to
low expression levels (reviewed in Liang and Pardee. 1995).
Also. many immediate-early genes play specific roles in development and arc
only expressed for shan periods or time. Therefore the time period from which the RNA
was obtained for experimentation is crucial. Stage 8 in the Xenopus blastula embryo lasts
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approximately 2 hours. depending on environmental temperature. 'The rate of
development also varies naturally depending on the male and female frogs used.
The differential display was conducted by Yu Li, whereas I did all of the further
analysis. Therefore, if I isolaled the RNA al a different point in Slage 8 than Yu Li. this
could make a difference in expression levels of the genes being studied. Subjective
differences in staging the embryos from person to person and in Xenopus developmental
rate could not be avoided.
Expression of the gene represented by Sample 14 was not detected by Northern
blotting or PeR in FGF-m:ated explants or in developing embryos. This is unusual, as
one would expect 01.1 least minimal expression in FGF-treated explanlS because the
original differential display was conducted under the same conditions. So even with
subjective differences in embryo staging, Sample 14 should be detected by PCR.
4.3.3 Base Pair Subslitulioas
None of the DNA fragmenlS cloned from the same differential display bands
possessed exactly the same DNA base pair sequence. There was at least one difference in
the nucleotide sequence in all matching samples. For example. there are two base pair
differences between Samples 17 and 22. Sevcral cxplanations can be offcred for thcse
differences.
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During PeR. if the conditions are not SU'ingent enough. a substitution enor may
occur during the amplification step and result in me further ampliflCa1ion of the fragment
with an altered sequence. For in.sunce. if an 'A' is replaced by a 'T' within the first
round of amplificalions. all of the subsequent products will have that error.
Sequencing errors may also arise. mostly due to incorrectly reading the
sequencing film. Erron in sequence reading are due mostly to multiple bands in one lane
or aberrations in the polyacrylamide gel.
4.4 Genbank Protein Matches, Potential Functional Domains and
Expression
The sequences of the new DNA fragments from the differential display gel were
sent to a Genbank in order to detennine whether they were novel or previously cloned
genes. A Gcnbank search is beneficial for elucidating cacalytic and functional domains.
which have been well researched and are often easily recognized. Identifying functional
and catalytic domains is quite useful for elucidating possible functions for the cDNA
fragments from novel genes. This infonnation. along with expression studies. can offer a
great deal of infonnation regarding the potential fGF early response genes. Even though
it was nOl possible to conclude fGF regulation of the new samples. several of them
appear to be developmentally expressed (Samples 3.11, and 30) which is of great interest
on its own and warrants further investigation.
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4.4.1 Sample 24 is 99% Identlcalto the c·mos Proto-oncogene
As previously described, a nucleotide Genbank search revealed 99% identity at
the nucleic acid level between Sample 24 and X~nbPUS ("-mOJ. This observation was
made quite late in the study and due to time constraints this matter could flO( be studied
further.
MOS is a serine/threonine kinase that plays a vital role in Xenopus oocyte
maturation (Reviewed by Gebauer and Richter. 1997). Nonnally, venebratc oocytes
undergo a growth arrest afler prophase I. At this stage, many immature mRNA species
are present in the cell. possessing sOOn poly A+ tails. Upon oocyte stimulation wilh
progesterone or insulin, c·mo! rnRNA is poIyadenylalcd. and prolein uanslation begins.
MOS initiates a MAPK kinase phosphorylation cascade responsible for polyadcnylation
of other mRNAs and maturation of the oocyte (Sheets t!1 al., 1995). Injection of antisense
c-mos RNA into immature oocytes blocks polyadenylation of many important cellular
mRNAs such as Histone B4 and cyclins AI and 81 (DeMoor and Richter. 1997).
Normally. MOS is not usually found in somatic cells. only mawring oocytes (reviewed
by Vande-Woude. 1994).
The full sequence of the gene represented by Sample 24 must be: obtained in order
to confinn whether it is c·mos or a different gene. which shares a region of identity with
c-mos. Further work must also be: done to detennine if Sample 24 is present due to
contamination or an actual FGF regulated gene. A PCR reaction to test whether C-!MS is
eltpressed due to FGF treatment of animal cap uplants would be: a worthwhile venture to
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confirm whether Sample 24 is a product of contamination or it is actually expressed in
the developing embryo.
4.4.2 Potential FGF- Regulated Genes
4.4.2.1 Band V, Samples 1 and 3
Genbank Protein Matches aDd Potential FundioDai Domains
Samples I and 3 from Band V represent a novel gene possessing significant
similarity to four known prO!eins and one hypothetical protein. The Bovine hypothetical
IlkDa protein upstream of parathyroid honnone gene was not useful in identifying
function, as its own function is unknown.
The four other proteins bearing sequence similarity to Band V were quite useful
in suggesting potential functional domains. The highest degree of similarity was to the
a1tematively spliced region of the Human Myocyte- Specific Enhancer Factor 2 (aMEF2)
(Yu eta/., 1992).
MEF2 is a member of the MADS (MCM I-Arg8o-!&amous...geficens-~RF) box
transcription factor family, which are defined by a conserved motif (MADS-box) within
the DNA binding domain. The amino-tenninal MADS box specifies the DNA binding
specificity and the carboxy-tenninal defines the dimerization domain whereby two
MADS-box proteins interact. The MEF and related to serum response factor (RSRF)
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proteins form a subfamily of MADS transcription factors (reviewed by Sh<n and
Sharrocks,I995).
MEF2 binds to muscle speciftc enhancers and promoters and is induced in non·
muscle cells by MyoD. It has been implicated in the formation of muscle cells. but is not
sufficiem to induce the formation of the full muscle phenotype (Yu et ai.• 1992). In
murine studies, MEF2 has been identified very early in development (day 8.5·9 p.c.) in
mesodennal1y derived regions associated with heart and skeletal muscle and are thought
to be imponam for their fonnation (Subramanian and Nadal-Ginard, 1996).
In particular. Band V is similar to the alternatively spliced region of MEF2 (see
Figure 4.1). Alternative splicing is thought to be imponant for tissue specific expression
of MEF2. The exact function of lhe alternatively spliced region is unknown, however, in
DNA binding tests, the alternative form of MEf shows a several-fold increase in DNA
binding than the original form. Therefore the alternative peptides are proposed
modulators of DNA binding via lhe adjacent MADS domain (Yu t!t al.• 1992).
The region of aMEF2 that is similar to Band V is identical to another procein,
RSRFC9 lrelated to ~rum response factor C9). RSRFC9 is thought to be analogous to
aMEF2, except RSRFC9 does not contain lhe alternatively spliced region labeled B in
Figure 4.1 (Pollock and Treisman. 1991). There is no specific functional information
available regarding the RSRFC9.
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Figure 4.1 Schematic Diagram of MEF2. The diagonally striped region contains the
alternatively spliced region bearing similarity to Band V. The Alternatively spliced
region found in RSCRFC9 but not MEF2 is the area labeled B.
The gene with the second highest similarity region to Band V is the T-cel!
receptor (TCR) gamma chain V·J·C region (clone 197GI) from Ovis aries. T-cell
receptor is an important antigen receptor found on the T-cells of the immune system that
regulates activation and growth of T-Iymphocytes. Activation of T cell receptor by
specific antigens results in activation of protein tyrosine kinases and initiation of several
signal transduction cascades, including phospholipase C y I and phosphatidylinositol 3'-
hydroxy kinase (reviewed by Cantrell, 1996).
The specific heterodimerization of the TCR chains (a, p, 5 and y) and genetic
rearrangements confer antigen specificity (Hein et at.. 1990). The 0 and y dimers only
form 5% of TCR in adult humans, whereas they are much more abundant in sheep (origin
of the Band V matching protein).
Band V is specifically similar to the V-J-C (variable-joining-constant) region of
the y chain which is at the immediate amino-terminal end of the protein responsible for
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conferring antigen specificity. The matching region is directly amino-terminal of the
constant region conserved between sheep. human and mouse ychains (Hein et aI., \990).
The third protein wilh similarity to a region of Band V is H. sapiens Meprin A
Beta·Subunit Precursor (MAP), also known as, endopcptidase-2. Meprin is a dimcric
metalloproteinase from lhe astacin family composed of a and Pchains linked covalently
through disulfide bonds. It is anchored [0 lhe cell membrane and found primarily in lhe
brush border membranes of the human intestine (Uren and Vaux. 1996).
A basic schematic diagram of lhe Meprin p-Subunit is shown in Figure 4.2. The
Astacin domain is responsible for proteolytic activity. lhe function of the MAM (found in
meprin. 6,-5 protein and receptor protein·tyrosine phosphatase micron) domain is
unknown (Marchand et aI., 1996). The TRAFC domain is a region similar to a region of
TRAF <!umor necrosis factor receptor·!Ssociated factors). whose function is also
unknown. Band V possesses similarity to Meprin A precursor in a region of the MAM
domain and another region thought to be within lhe Astacin domain (Uren and Vaux.
1997).
N·terminal
1 2 Astacin[I]-n::::::::::::::::!
N.......
I
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MAM
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Sima! PeDtide
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C·......aa1
TRAFC 3 45
[I]
Figure 4.2 Schematic Diagram of lhe Meprin p-Subunit. Revised from Uren and Vaux.
\997.
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The fifth match to Band V was Bos taurus Myosin I heavy chain-like protein
(Mille), or brush border myosin I. It was the only match that occurred in the minus
reading frame of Band V as presented in Figure 3.4 (Page 7S). MUIC is found primarily
in the intestinal brush boarder. its mRNA has been identified at very low levels within
other tissues, including liver, testis. lung, brain and kidney. It is thought to playa role in
intracellular trafficking. MlliC contains three functional domains; the 78kDa ATPase
and actin binding domain, the 12kdacalmodulin·binding domain and the 20kDa carboxy-
terminal tail that binds phospholipids (Reviewed by Coluccio, 1997).
Band V is similar to MUIC in two regions; the first is 57 amino acids carboxy-
terminal of the ATP binding consensus sequence. The second region of similarity is
between amino acids 823-840 of 1043 total amino acids. This is the alpha helix region of
the protein (Hoshimaru and Nakanishi, 1997).
Although no definite assignment of functional domains can be made to regions of
Band V at this point, based on regions of similarity to known proteins. possible functional
motifs may be suggested. If one were to consider the S' to 3' orientation of Band V
given in Figure 3.5 (Page 81) as the correct orientation. the domains of similarity to
known genes would be as shown on the top region of Figure 4.3.
Similarity of aMEF·2 with Band V is close to the carboxy-tenninal of the
proposed protein. The region of similarity docs not bind DNA itself. but is thought to
facilitate DNA binding for aMEF·2 and may playa similar role in Band V protein. The
TCR and MAP regions of similarity to Band V overlap with the hypothetical protein (liP)
region. Since the region of similarity to the TCR is within the amino-tenninal
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extracellular immunoglobulin domain of the receptor, the protein represented by Band V
may also have a protein-binding domain. Band V is also similar 10 the extracellular
Asticin proteolytic domain of MAP, which is also a membrane bound protein.
These similarities suggest that Band V could possibly possess regions that
facilitate DNA binding, bind other proteins and/or have a proteolytic activity. The
regions of similarity are not identical to the known proteins, and only suggest possible
functional regions.
N·terminal C·terminal
Figure 4.3 Schematic Diagram of Band V Showing Regions of Similarity with Genbank
Matches. Legend: T-cell Receptor (TCR), Bovine Hypothetical Protein (BHP), Meprin A
Precursor (MAP), Myocyte Enhancer Factor·2 (MEF·2), Myocin I Heavy Chain-like
Protein (MillC).
If the opposite orientation is the actual correct reading frame for Band V,
similarity to MillC reveals potential functional domains. The matching region on the left
of Figure 4.3 may represent an atpha+helical region, while the matching region 10 the
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right may be involved with ATP binding as these are the function of the regions in
Mrnc.
The above observations arc to describe regions of similarity only and to suggest
possible functional regions. More of the sequence must be detennined and more studies
done before any definitive function for Band V can be made.
Expression
Band V is unique in this study because it is downregulated by FGF ueatment.
However, Band V is expressed at Stage 8, when mesoderm induction occurs, and FGF·2
is expressed. It may be that Band V is normally imponant in development at stage 8, but
its gene is repressed by FGF treatment. Downregulation in response to FGF suggests that
the FGF signal cascade activates proteins that inhibit Band V gene expression.
Other than Stages 8-9, Band V was only found to be expressed at neurula Stage
15, signifying that the gene product may playa role in neural development.
The appearance of three bands on the mRNA Northern blot probed with Sample 3
suggests that there is more than one mRNA species annealing to the probe. Thus it is
possible that Band V is from a member of a gene family. It is also possible that its
mRNA is alternatively spliced. in a fashion similar to aMEF-2.
'"
4.4.2.2 Bands VIA and VIB, Samples 14 and IS
Genbank Protein Matches and Potential Functional Domains
Samples 14 and IS from Band vm exhibited similarity to a serine proteinase
inhibitor 2.4 (SPI2.4) and contrapsin-related protein MC-1 precursor. which possess the
same amino acid sequence within the matching area.
SPI 2.4 is a member of the SPI protein superfamily in mouse. SPls play roles in
blood coagulation, complement cascade and inflammatory response and is abundantly
expressed in the liver (Inglis and Hill, 1991). Mouse contrapsin in a major trypsin
inhibitor. highly similar to the human al-antichymotrypsin (Ohkubo et al., 1991).
Bands vm and VIA are similar to the reactive centre of the SPl 2.4 (and
proposed reactive centre of contrapsin precursor) (Figure 4.4). The reactive centre is the
region of the SPI in which protcinases attack; upon attack, the proteinase is inactivated.
The proteolytic specificity of the SPI is primarily detennined by a single amino acid
within the reactive centre, the PI residue, however the other amino acids in the reactive
centre are important for specificity and efficiency of inhibition. Among different family
members, the reactive centre itself is also highly variable (Inglis and Hill. 1991).
Since Bands VIA and VIB yield similarity to the reactive centre of a proteinase
inhibilOr. it may also playa role as an enzyme inhibitor. However. more of the sequence
of the protein represented by Bands VIAIB must be obtained before any funher
conclusions can be made about its function.
13.
su 4-KCYRDVYDIXXXXXXXXGl"ISFYKNGKSMTMVAQFGKPFFLWQ!iTSVQ'1'RSF-l39
K DV.. GFI +++.. 'l'H QF +PF +V+ !iT VQT F
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t
I?iI
Figure 4.4 Reactive Centre of Serine Proteinase Inhibitor (SPO Similarily with Sample
14. PI is the residue that detennines enzyme specificity. The reactive cenlre is in bold.
Expression
None of the methods used in this sWdy were able to confinn expression of Bands
VlA and vm as examined through Sample 14. Due to low expression levels, many of
the other samples tested by NOM-hem blot were not detected. However, Sample 14 was
not detected in FGF treated animal cap explants by PeR. A gene upregulated by FGF
should be expressed at high enough levels to be detected by sensitive PCR methods. The
specific Sample 14 primers were able to amplify Sample 14 plasmid eDNA, therefore the
problem with PCR amplification was not thought to be due primer design.
There are several possibilities for the problem of Sample 14 detection by PeR.
The gene may be expressed at very low levels, even if upregulated by FGF. Another
possibility is that Bands VIA and vtB may not be a product of the Xenopus genome, but
a result of contamination from another source.
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4.4.2.3 Bands 11 and 12, Samp... 17 and Z2
Genbank Protein Matches aDd Potential Functional Domains
Samples 17 and 22. from Bands II and 12 respectively, yield amino acid
similarity to a hypothetical 19.7 kDa protein (open reading frame 2) from a fungus
mitochondrial plasmid. The 19.7kDa protein from the fungus Ascobolus immersus is a
proposed DNA polymerase according to open reading frame (ORF) I, which is in the
positive orientation. Similarity to Band 111\2 DNA fragment is in ORF 2. which is a
short ORF in a minus reading frame. opposile of the suspected correct reading frame.
Thus this information was not useful in determining the function of the matching regions
(Kempken el at.. 1989).
Expression
Bands 11 and 12 mRNA were not detected by Northern blotting. but were
detected in Stage 8 Xenopus embryos by RT·PCR. In the PeR experiment. the gene
product was shown to be upregulated in response to FGF uc:atment. This suggests thal
the protein transcribed from this gene plays a specific role in development at Stage 8. Its
upregulation by FGF in animal cap explants adds to the validity of this hypothesis,
however this experiment must be repealed several times in Ofder to make a final
conclusion regarding FGF regulation.
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4.4.2.4 Band 22, Samples 29 and 30; a 146kDa Nuclear Protein
Samples 29 and 30 from Band 22 yielded 91% identity to a 146kDa Xenopus
widespread nuclear prOiein (NP). From the high degree of identity, it is assumed that
Band V represents the same protein. NP is localized within the nucleus in nuclear
speckles. which contain the ribonucleoprotein particles and other splicing factors
invloved in processing RNA. It is thought to be a widespread nuclear protein that co-
localizes with the mammalian splicing factor SF3b and is thus a proposed component of
this factor (Schmidt-zachmann el al., 1998).
NP possesses a region of lhreonine·proline phosphorylation sites for cyetin
dependent kinase (CDK). CDK is one of a family of kinases that play imponant roles in
the regulation of cell division cycles and gene transcription (reviewed in Morgan. 1991).
NP also has phosphorylation sites for PKC. cAMP dependent protein kinase (protein
kinase A. PKA) and casein kinase n (CKlt) (Schmidt-zachmann et al.• 1998).
PKC plays diverse roles in cell differentiation. growth. cell cycle control and
tumorigenesis (Livneh and Fishman. 1997) and is a well-known effector of diacyl
glycerol in the PLCyl pathway (Figure 1.5. Page 27). PKA is also involved in a wide
variety of cellular functions and is a key molecule in a phosphorylation cascade as an
effector of the adenylale cyclase membrane protein (Fantozzi et al.. 1994). Casein kinase
II is a widely effective serine/threonine kinase required for cell cycle progression and cell
viability. CKll is expressed ubiquitously. and at high levels in proliferating cells (Pinna
and Meggio. 1997).
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As previously described. Band 22 is 84% identical to a region of the C. l!l~g(JtU
Cosmid T08AII.2. cloned as a result of the Nematode seq~ncin& project (Wilson ~t oJ.•
1994). A portion of a corresponding human prolein was 91.7S% identical to the Xenopus
protein. suggesting that they are homologous molecules (Schmidt-zachmann ~t al.•
1998). The high level of similarity suggesu that this gene has been well conserved
throughout evolution. any may playa vital role in cellular processes.
Immunolocalization studies with NP reveals that it is present in the developing
embryos as well as the follicle epithelial cells surrounding the oocytes. fibroblasts and
olher dennal cells, cardiomyocytes. endothelial cells and erythrocytes. In erythrocytes
thai are inactive in transcription and replication. NP protein was present suggesting that it
is a general component of the nucleus and is not dependent on RNA or DNA synthesis
(Schmidt-Zachmann et oi.• 1998).
Expression
My studies were noI able to confinn the upregulation of Band 22 expression by
FGF-2 in X~nopus animal cap cxplants. Three of the four RT·PCR experiments revealed
that Band 22 was upregulated by FGF treatment. In one Northern blot. a more reliable
source for studying expression. Band 22 mRNA doubled in response to FGF treatment.
Two other Northern blots revealed that Band 22 expression is approximately the same or
decreased in response to FGF. The conOicting results. especially with Nonhern blots.
make it impossible to conclude whether Band 22 is upregulated by FGF.
Schmidt-Zachmann and colleagues (1998) suggest that NP is a ubiquitous protein.
''0
My Northern blotting experiments reveal that Band 22 is expressed throughout Xf!nopus
development. There is a slight increase in expression from first cleavage to Stage 8-9,
and then a decrease at gastrula stage 10-10.5. There is an increase in expression after
gastrulation and then a decrease again at mid to late tailbud, Stages 30-35. Increase in
expression at Stage 8·9 would be expected because this is the stage at which the zygotic
expression begins, presumably when increased levels of splicing occur. This also marks
the onset of mesoderm induction, when NP could also play an imponant role.
4.5 Future Studies
There are several experimental approaches that may be taken to further study
FGF-2 response genes in Xf!nopus lOi!vis. One approach would be to start fresh with a
new differential display. This way. one could check whether the same genes are
upregulated by FGF in the second experiment as the first.
Performing 'slot blotting' is said to be an effective method of confirming wltether
genes are differentially expressed, and a large number of genes may be checked quickly,
before too much time is spent studying them (Moo f!l al.• 1994). For example, in a
differential display conducted by Mou and colleagues. only 8 out of 38 DNA fragments
were differentially expressed according to the slot blot. This method saved the
researchers a lot of research time that could have been spent working on other methods
(Mou etal., 1994).
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The slol blot method involves spouing the potential differentially expressed DNA
fragments onto a nylon membrane and probing the membrane with radiolabeled eDNA
reverse transcribed from mRNA isolated from the different experimental conditions. For
example. one could probe with cDNA from FGF treated and untreated explants. This is a
reverse of the methodology used for Nonhem blotting. and many fragments may be
blotted on one membrane and tested at one time. However. since a large amounl of the
potential differentially expressed fragment may be hybridized to the membrane. this
process is more sensitive than Nonhem blouing.
As discussed. it has been difficult to quantitate expression levels of the new genes
by peR. One option to help quantitation of the PCR products would be to amplify
known quantities of synthetic DNA and make a standard curve. Thus. one could compare
unknown samples with the standard curve.
A major obstacle to overcome with Samples 3 and 17 is to be able to obtain a
larger piece of the DNA sequence. One would have to use more specialized cloning
methods. An option for Sample 17 (which may also work for Sample 14) would be to
create a cDNA library made at the developmental stage at which the samples are
expressed. or made from FGF treated explant cDNA. For example. an option for cloning
Sample 3 in the future would be to create a new cDNA library of stage 8 embryos and to
use a modified. more sensitive cloning technique.
A possibility for future studies would be to continue working on the samples that.
have already been isolated. Samples 3. 14, 17. and 30. Samples 3. 17 and 30 are quite
interesting because they have demonstrated differential developmental expression. One
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approach would be to conduct spatic)-[emporal analyses. One could treat embryos at
second cleavage wilh a vilal dye 10 label the dorsal end. Then at various stages of
development. explants could be cut from each region of the embryo. RNA could be
isolated and RT·PCR conducted to determine when and where the genes are expressed.
Another experimem that would be of interest would be to examine expression of
the genes in adult tissues. One could also search for homologues in other species
including human. Examining differential expression in various tissues. normal and
cancerous would also be useful. One could also examine expression in response to other
mesoderm inducers. such as activin.
It would be wonhwhile to further experimem with RNAse prolection assay.
Since this method is quite sensitive to lower RNA levels. il may be useful for examining
dirferemial expression. This lime. however. it would be important to use both positive
and negative orientations for probing. as one does not know which is the sense strand.
Titration of a control RNA at known concentrations would also be useful. Titrating the
control RNA to levels that can no longer be detected will allow one to estimate the
minimum amount of sample RNA needed for detection on RNAse assay. Thus. the
amount of total explant/embryo RNA needed for the experimem may be calculated.
Further experimentation with Sample 24 expression would also be interesting in
light of its similarity to c·mos. PCRs testing FGF-regulation could be conducted to
determine whether c-mos is expressed in response 10 FGF treatment. This could be
performed quite quickly.
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There is great potential for future studies in developmentally expressed genes and
FGF early response genes and a vast amount of knowledge to be obtained in the area.
The more infonnation we obtain regarding developmental and FGF response genes. the
closer we are [0 elucidating the mysteries of both nonnal embryonic development and the
pathology of cancer.
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